ABI3

UniProt ID: Q9P2A4
Organism: Homo sapiens
Review Status: DRAFT
πŸ“ Provide Detailed Feedback

Gene Description

ABI3 (also known as NESH) is a member of the ABI (Abl interactor) family of adaptor proteins. It contains an N-terminal WAVE-binding domain, proline-rich regions, and a C-terminal SH3 domain. ABI3 functions as a component of the WAVE regulatory complex (WRC), occupying the Abi subunit position alongside WAVE2, CYFIP1, NAP1, and BRK1. Unlike its paralogs ABI1 and ABI2, ABI3 does not bind c-Abl and does not promote c-Abl-mediated phosphorylation of WAVE2 (PMID:17101133). ABI3-containing WAVE2 complexes are functionally distinct from ABI1-based complexes, showing reduced WAVE2 translocation to the plasma membrane and impaired lamellipodium formation (PMID:26428302). ABI3 is regulated by phosphorylation at S213, S216, and S342, with non-phosphorylated ABI3 preferentially incorporated into the WRC. ABI3 is enriched in microglia in the brain and is a replicated Alzheimer disease risk gene (S209F variant, OR~1.43). In mouse models, Abi3 loss impairs microglial ramification and tissue surveillance. ABI3 also shows tumor-suppressive properties when ectopically expressed, suppressing cell motility and metastatic dissemination (PMID:11956071) and inducing cellular senescence (PMID:21223585).

Existing Annotations Review

GO Term Evidence Action Reason
GO:0048858 cell projection morphogenesis
IBA
GO_REF:0000033
ACCEPT
Summary: IBA annotation based on phylogenetic inference from ABI family orthologs across species. ABI3 is a WRC component and the WRC is essential for actin-dependent cell projection formation. ABI3-containing WAVE2 complexes influence protrusion formation, though ABI3 specifically impairs lamellipodial protrusions while potentially favoring ventral protrusions (PMID:26428302). The term 'cell projection morphogenesis' is appropriately general for this family-level annotation.
Reason: As a WRC component, ABI3 modulates actin-dependent cell projections. The IBA annotation at this level of specificity is appropriate given the phylogenetic conservation of this function across ABI family members.
Supporting Evidence:
PMID:26428302
the formation of peripheral lamellipodial structures was disturbed, suggesting that the NESH/Abi-3-based WAVE2 complex was unable to help produce lamellipodial protrusions
GO:0001764 neuron migration
IBA
GO_REF:0000033
KEEP AS NON CORE
Summary: IBA annotation inferred from orthologs. ABI family members participate in neuron migration via actin regulation through the WRC. ABI3 is expressed in the brain, particularly in microglia (not neurons primarily), but WRC function in neuron migration is well-established for ABI1/ABI2 orthologs.
Reason: Neuron migration is a conserved function of ABI family members through the WRC. However, ABI3 is primarily enriched in microglia rather than neurons in the brain. The IBA inference from orthologs is phylogenetically reasonable but this is not a core function of ABI3 specifically.
GO:0030027 lamellipodium
IBA
GO_REF:0000033
ACCEPT
Summary: IBA annotation for lamellipodium localization based on phylogenetic inference. ABI3 localizes to lamellipodia as shown by IDA evidence in PMID:17101133. This is consistent with its role as a WRC component, since the WRC drives Arp2/3-dependent actin polymerization at the leading edge.
Reason: Supported by direct experimental evidence (IDA from PMID:17101133) and consistent with ABI3 function as a WRC component. Lamellipodium localization is a core aspect of ABI3 biology.
Supporting Evidence:
PMID:17101133
Immunoprecipitation revealed that NESH (Abi-3) is present in the Abi/WAVE complex
GO:0031209 SCAR complex
IBA
GO_REF:0000033
ACCEPT
Summary: IBA annotation for SCAR/WAVE complex membership. This is very well supported by multiple IDA studies (PMID:17101133, PMID:26428302) and IP-MS data (Moraes et al. 2017). ABI3 is a bona fide component of the WAVE regulatory complex, occupying the Abi subunit position.
Reason: Core function of ABI3. Membership in the SCAR/WAVE complex is the defining biochemical role of ABI3. Strongly supported by multiple independent experimental studies.
Supporting Evidence:
PMID:17101133
Immunoprecipitation revealed that NESH (Abi-3) is present in the Abi/WAVE complex. Our results suggest that NESH (Abi-3), like Abi-1 and Abi-2, is a component of the Abi/WAVE complex
PMID:26428302
NESH/Abi-3 was ectopically expressed in NIH3T3 cells, in which Abi-1, but not NESH/Abi-3, is expressed. The expression of NESH/Abi-3 caused degradation of endogenous Abi-1, which led to the formation of a NESH/Abi-3-based WAVE2 complex
GO:0035591 signaling adaptor activity
IBA
GO_REF:0000033
ACCEPT
Summary: IBA annotation for signaling adaptor activity. ABI3 functions as an adaptor protein within the WRC, linking upstream signals to actin cytoskeleton regulation. It contains an SH3 domain and proline-rich regions typical of adaptor proteins. The SH3 domain interacts with PAK and IRSp53 (PMID:11956071, PMID:18480067).
Reason: ABI3 is a well-characterized adaptor protein. Its SH3 domain mediates protein-protein interactions and it serves as a bridge within the WRC to couple signaling to actin regulation. This accurately captures the molecular function of ABI3.
Supporting Evidence:
PMID:11956071
The SH3 domain of NESH seems to interact with p21-activated kinase (PAK), which is involved in regulation of cell motility
GO:0098858 actin-based cell projection
IBA
GO_REF:0000033
ACCEPT
Summary: IBA annotation for actin-based cell projection localization. ABI3 localizes to actin-based structures as a WRC component. Experimental evidence shows it at lamellipodia and potentially invadopodia (PMID:26428302).
Reason: Consistent with ABI3 function as a WRC component that regulates actin-based protrusions. Well-supported by the IDA evidence for lamellipodium localization and the broader role in actin-based structures.
GO:0030334 regulation of cell migration
IBA
GO_REF:0000033
ACCEPT
Summary: IBA annotation for regulation of cell migration. Strongly supported by experimental evidence showing that forced expression of NESH/ABI3 suppresses cell motility and metastatic dissemination (PMID:11956071). ABI3 modulates migration through its effects on WRC-dependent actin dynamics.
Reason: Core function of ABI3. Regulation of cell migration is one of the best-characterized biological roles of ABI3, supported by multiple independent studies.
Supporting Evidence:
PMID:11956071
every clone of NESH transfectants caused a marked reduction in motility, although the clones exhibited no significant differences in intrinsic cell growth compared with the control cells in vitro
GO:0005737 cytoplasm
IEA
GO_REF:0000044
ACCEPT
Summary: IEA annotation from UniProt subcellular location mapping. Cytoplasmic localization is supported by IDA evidence (GO_REF:0000054) and NAS from PMID:11956071. UniProt states ABI3 localizes to the cytoplasm and colocalizes with PAK2 at the leading edge of cells.
Reason: Consistent with experimental evidence for cytoplasmic localization. Broad IEA mapping is acceptable given strong experimental support.
GO:0005515 protein binding
IPI
PMID:16189514
Towards a proteome-scale map of the human protein-protein in...
MARK AS OVER ANNOTATED
Summary: Protein binding annotation from high-throughput interactome study. While ABI3 does bind multiple proteins, 'protein binding' is uninformative. The more specific 'signaling adaptor activity' (GO:0035591) already captures the molecular function.
Reason: 'Protein binding' is too vague to be informative. ABI3 does bind proteins but the specific adaptor function is better captured by GO:0035591 (signaling adaptor activity). High-throughput interactome data does not provide mechanistic insight.
GO:0005515 protein binding
IPI
PMID:17101133
NESH (Abi-3) is present in the Abi/WAVE complex but does not...
MARK AS OVER ANNOTATED
Summary: Protein binding from PMID:17101133 which demonstrated ABI3 interacts with WAVE2 complex components. This is more informative than generic protein binding as it reflects the specific WRC interaction, but the term itself is uninformative.
Reason: While the underlying interaction data from PMID:17101133 is high quality and shows specific binding to WAVE complex components, 'protein binding' is not an informative GO term. The SCAR complex membership and signaling adaptor activity annotations better capture this function.
Supporting Evidence:
PMID:17101133
Immunoprecipitation revealed that NESH (Abi-3) is present in the Abi/WAVE complex
GO:0005515 protein binding
IPI
PMID:19060904
An empirical framework for binary interactome mapping.
MARK AS OVER ANNOTATED
Summary: Protein binding from high-throughput binary interactome mapping study.
Reason: Generic 'protein binding' from high-throughput study is uninformative. More specific molecular function terms already exist for ABI3.
GO:0005515 protein binding
IPI
PMID:21516116
Next-generation sequencing to generate interactome datasets.
MARK AS OVER ANNOTATED
Summary: Protein binding from next-generation sequencing interactome dataset.
Reason: Generic 'protein binding' from high-throughput study is uninformative.
GO:0005515 protein binding
IPI
PMID:25416956
A proteome-scale map of the human interactome network.
MARK AS OVER ANNOTATED
Summary: Protein binding from proteome-scale interactome mapping.
Reason: Generic 'protein binding' from high-throughput study is uninformative.
GO:0005515 protein binding
IPI
PMID:27107014
An inter-species protein-protein interaction network across ...
MARK AS OVER ANNOTATED
Summary: Protein binding from inter-species protein-protein interaction network study.
Reason: Generic 'protein binding' from high-throughput study is uninformative.
GO:0005515 protein binding
IPI
PMID:29892012
An interactome perturbation framework prioritizes damaging m...
MARK AS OVER ANNOTATED
Summary: Protein binding from interactome perturbation framework study.
Reason: Generic 'protein binding' from high-throughput study is uninformative.
GO:0005515 protein binding
IPI
PMID:32296183
A reference map of the human binary protein interactome.
MARK AS OVER ANNOTATED
Summary: Protein binding from reference binary protein interactome map.
Reason: Generic 'protein binding' from high-throughput study is uninformative.
GO:0005515 protein binding
IPI
PMID:40205054
Multimodal cell maps as a foundation for structural and func...
MARK AS OVER ANNOTATED
Summary: Protein binding from multimodal cell maps study.
Reason: Generic 'protein binding' from high-throughput study is uninformative.
GO:0042802 identical protein binding
IPI
PMID:25416956
A proteome-scale map of the human interactome network.
ACCEPT
Summary: Self-interaction of ABI3 detected in high-throughput interactome study. UniProt interaction data confirms ABI3 self-interaction (NbExp=4).
Reason: ABI3 homodimerization is supported by multiple independent high-throughput studies and is recorded in IntAct. This is more informative than generic 'protein binding' and may reflect a functional oligomerization relevant to WRC assembly or regulation.
GO:0042802 identical protein binding
IPI
PMID:32296183
A reference map of the human binary protein interactome.
ACCEPT
Summary: Additional evidence for ABI3 self-interaction from reference interactome map.
Reason: Independent confirmation of ABI3 homodimerization. Duplicates with different references are acceptable.
GO:0002357 defense response to tumor cell
IEA
GO_REF:0000120
ACCEPT
Summary: IEA annotation from combined automated methods, likely transferred from mouse ortholog data. The IMP annotation from PMID:21223585 provides direct experimental support showing ABI3 ectopic expression reduces tumor growth.
Reason: Consistent with the IMP-supported annotation from PMID:21223585 and with broader literature on ABI3 as a tumor suppressor. The IEA is broader but not incorrect.
GO:0010593 negative regulation of lamellipodium assembly
IEA
GO_REF:0000107
ACCEPT
Summary: IEA annotation transferred from mouse ortholog. Supported by experimental evidence in PMID:26428302 showing that ABI3/NESH expression in NIH3T3 cells reduced WAVE2 translocation to the plasma membrane and disturbed lamellipodial formation.
Reason: This is a well-supported function of ABI3. The ABI3-based WAVE2 complex is functionally distinct and impairs lamellipodial protrusion formation compared to ABI1-based complexes.
Supporting Evidence:
PMID:26428302
the translocation of WAVE2 to the plasma membrane was significantly reduced and the formation of peripheral lamellipodial structures was disturbed
GO:0030027 lamellipodium
IEA
GO_REF:0000120
ACCEPT
Summary: IEA annotation for lamellipodium localization. Consistent with IDA evidence from PMID:17101133 and IBA annotation.
Reason: Redundant with IBA and IDA annotations but not incorrect. Lamellipodium localization is well established for ABI3.
GO:0031209 SCAR complex
IEA
GO_REF:0000120
ACCEPT
Summary: IEA annotation for SCAR complex membership. Consistent with IDA annotations from PMID:17101133 and PMID:26428302.
Reason: Core function. Redundant with IDA annotations but acceptable.
GO:0098794 postsynapse
IEA
GO_REF:0000107
KEEP AS NON CORE
Summary: IEA annotation transferred from rat ortholog via Ensembl Compara. ISS annotations from ARUK-UCL also support postsynaptic localization (dendritic spine, postsynaptic density). The WRC functions in dendritic spine morphogenesis, supporting synaptic localization. However, ABI3 is primarily enriched in microglia rather than neurons.
Reason: While WRC-mediated actin regulation at the postsynapse is conserved for ABI family members, ABI3 is primarily expressed in microglia in the brain, not neurons. The synaptic annotations may be more relevant to ABI1/ABI2 and transferred to ABI3 by orthology. Keep as non-core pending direct evidence in neurons.
GO:0098885 modification of postsynaptic actin cytoskeleton
IEA
GO_REF:0000107
KEEP AS NON CORE
Summary: IEA annotation from rat ortholog. WRC-dependent actin modification at postsynapses is a known function of ABI family members. However, ABI3 is primarily microglial rather than neuronal in the brain.
Reason: Plausible by orthology and WRC function but ABI3 is not the primary ABI family member in neurons. This function may be more attributable to ABI1/ABI2.
GO:0098978 glutamatergic synapse
IEA
GO_REF:0000107
KEEP AS NON CORE
Summary: IEA annotation transferred from rat ortholog. Glutamatergic synapse localization may be more relevant to ABI1/ABI2 given ABI3 enrichment in microglia.
Reason: Transferred from rat ortholog. ABI3 is microglia-enriched in brain tissue and not primarily neuronal. This annotation may reflect function of other ABI paralogs rather than ABI3 specifically.
GO:1903077 negative regulation of protein localization to plasma membrane
IEA
GO_REF:0000107
ACCEPT
Summary: IEA annotation from mouse ortholog. Supported by experimental evidence showing that ABI3 expression reduces WAVE2 translocation to the plasma membrane (PMID:26428302).
Reason: Well-supported by experimental data. ABI3-containing WAVE2 complexes show reduced translocation to the plasma membrane compared to ABI1-containing complexes, consistent with this annotation.
Supporting Evidence:
PMID:26428302
the translocation of WAVE2 to the plasma membrane was significantly reduced
GO:0030036 actin cytoskeleton organization
ISS
GO_REF:0000024
ACCEPT
Summary: ISS annotation transferred by curator judgment. ABI3 participates in actin cytoskeleton organization as a WRC component. The WRC activates Arp2/3-mediated actin nucleation and polymerization.
Reason: Core function of ABI3. As a WRC subunit, ABI3 directly participates in actin cytoskeleton organization. Well-supported by multiple studies showing effects on lamellipodia, cell protrusions, and actin-based structures.
GO:0002357 defense response to tumor cell
IMP
PMID:21223585
ABI3 ectopic expression reduces in vitro and in vivo cell gr...
KEEP AS NON CORE
Summary: IMP annotation from PMID:21223585 showing that ABI3 ectopic expression reduces tumor growth in vitro and in vivo in thyroid and colon carcinoma cell lines. ABI3 expression is frequently lost in carcinomas, and re-expression reduces transforming activity, anchorage-independent growth, and in vivo tumor formation.
Reason: The experimental evidence is solid showing tumor-suppressive effects of ABI3 re-expression. However, 'defense response to tumor cell' is not the most precise term for what was shown. The study demonstrates tumor suppressor activity through re-expression in cancer cells where ABI3 was silenced. This is more accurately described as negative regulation of cell proliferation or tumor suppression. Nevertheless, this is a secondary consequence of ABI3's primary role in actin regulation and cell migration, not a core evolved function.
Supporting Evidence:
PMID:21223585
Ectopic expression of ABI3 was sufficient to lead to a lower transforming activity, reduced tumor in vitro growth properties, suppressed in vitro anchorage-independent growth and in vivo tumor formation while, cellular senescence increased
GO:2000774 positive regulation of cellular senescence
IMP
PMID:21223585
ABI3 ectopic expression reduces in vitro and in vivo cell gr...
KEEP AS NON CORE
Summary: IMP annotation from PMID:21223585. ABI3 ectopic expression induced senescence in thyroid and colon carcinoma cells, accompanied by p21WAF1 upregulation and reduced ERK phosphorylation.
Reason: The experimental evidence for senescence induction is clear from PMID:21223585. However, this is likely a secondary consequence of ABI3 re-expression in cancer cells rather than a core evolved function. This effect is observed in the context of ectopic expression in cells where ABI3 was silenced, and the senescence phenotype may reflect disruption of oncogenic signaling rather than a primary ABI3 function.
Supporting Evidence:
PMID:21223585
cellular senescence increased. These responses were accompanied by the up-regulation of the cell cycle inhibitor p21 WAF1 and reduced ERK phosphorylation and E2F1 expression
GO:0031209 SCAR complex
IDA
PMID:17101133
NESH (Abi-3) is present in the Abi/WAVE complex but does not...
ACCEPT
Summary: IDA annotation from PMID:17101133 demonstrating ABI3 is present in the Abi/WAVE complex by immunoprecipitation. This is a key finding establishing ABI3 as a bona fide WRC component.
Reason: Core function. Direct experimental evidence from immunoprecipitation showing ABI3 is a component of the WAVE complex.
Supporting Evidence:
PMID:17101133
Immunoprecipitation revealed that NESH (Abi-3) is present in the Abi/WAVE complex. Our results suggest that NESH (Abi-3), like Abi-1 and Abi-2, is a component of the Abi/WAVE complex
GO:0043197 dendritic spine
ISS
GO_REF:0000024
KEEP AS NON CORE
Summary: ISS annotation transferred from a rat ortholog (F1M0R2) by ARUK-UCL curators. WRC components are known to localize to dendritic spines where they regulate spine morphogenesis. However, ABI3 is primarily microglial in the brain.
Reason: While WRC function at dendritic spines is conserved for ABI family members, ABI3 is microglia-enriched in the brain. This annotation may primarily reflect the function of ABI1/ABI2 in neurons, transferred by sequence similarity.
GO:0043198 dendritic shaft
ISS
GO_REF:0000024
KEEP AS NON CORE
Summary: ISS annotation transferred from rat ortholog. Similar considerations as for dendritic spine localization.
Reason: ABI3 is microglia-enriched rather than neuronal. This annotation may reflect function of other ABI paralogs. Keeping as non-core.
GO:0014069 postsynaptic density
ISS
GO_REF:0000024
KEEP AS NON CORE
Summary: ISS annotation transferred from rat ortholog. Postsynaptic density localization is well-established for WRC components, but ABI3 is primarily microglial.
Reason: Same reasoning as for dendritic spine. WRC function at the PSD is conserved for ABI family but ABI3 enrichment in microglia suggests this is not its primary localization context.
GO:0051015 actin filament binding
ISS
GO_REF:0000024
UNDECIDED
Summary: ISS annotation transferred from rat ortholog. ABI3 contains domains that could mediate interactions with actin-based structures, but direct actin filament binding by ABI3 itself has not been demonstrated. ABI3 functions as an adaptor within the WRC rather than directly binding actin filaments.
Reason: There is no direct evidence for ABI3 binding actin filaments. ABI3 interacts with actin-regulatory complexes (WRC) but its function is as an adaptor, not an actin-binding protein per se. The ISS transfer may be from a different ABI paralog with distinct biochemical properties. More evidence needed to confirm direct actin filament binding by ABI3.
GO:0061001 regulation of dendritic spine morphogenesis
ISS
GO_REF:0000024
KEEP AS NON CORE
Summary: ISS annotation from rat ortholog. WRC regulates dendritic spine morphogenesis but ABI3 is microglia-enriched, not primarily neuronal.
Reason: WRC function in spine morphogenesis is well-established but likely mediated by ABI1/ABI2 in neurons. ABI3 is primarily expressed in microglia.
GO:0099151 regulation of postsynaptic density assembly
ISS
GO_REF:0000024
KEEP AS NON CORE
Summary: ISS annotation from rat ortholog. Similar considerations as other synaptic annotations.
Reason: ABI3 is microglia-enriched and not the primary ABI paralog at neuronal synapses. Keep as non-core.
GO:1900028 negative regulation of ruffle assembly
NAS
PMID:18480067
Insulin receptor substrate protein 53 (IRSp53) as a binding ...
ACCEPT
Summary: NAS annotation from PMID:18480067 which identified IRSp53 as a binding partner of NESH/ABI3. The paper is a brief letter identifying the interaction. Previous work showed ABI3 over-expression blocked PDGF-stimulated membrane ruffling.
Reason: Negative regulation of ruffle assembly is consistent with ABI3's role in modulating actin-based structures. ABI3 overexpression blocks PDGF-stimulated membrane ruffling, and ABI3-containing WAVE2 complexes impair protrusion formation (PMID:26428302). This is a direct consequence of ABI3's core function in modulating WRC activity.
Supporting Evidence:
PMID:26428302
the translocation of WAVE2 to the plasma membrane was significantly reduced and the formation of peripheral lamellipodial structures was disturbed
GO:0010593 negative regulation of lamellipodium assembly
ISS
GO_REF:0000024
ACCEPT
Summary: ISS annotation from mouse ortholog. Strongly supported by experimental evidence in PMID:26428302 showing ABI3-containing WAVE2 complexes impair lamellipodium formation.
Reason: This is a core function distinguishing ABI3 from ABI1/ABI2. ABI3-based WAVE2 complexes are functionally distinct and impair lamellipodial protrusions.
Supporting Evidence:
PMID:26428302
the NESH/Abi-3-based WAVE2 complex was unable to help produce lamellipodial protrusions
GO:0031209 SCAR complex
IDA
PMID:26428302
The NESH/Abi-3-based WAVE2 complex is functionally distinct ...
ACCEPT
Summary: IDA annotation from PMID:26428302 providing detailed characterization of the ABI3-based WAVE2 complex. Demonstrated that ABI3 expression leads to degradation of endogenous ABI1 and formation of an ABI3-based WAVE2 complex.
Reason: Core function. Independent confirmation of SCAR/WAVE complex membership with detailed functional characterization of the distinct ABI3-containing complex.
Supporting Evidence:
PMID:26428302
The expression of NESH/Abi-3 caused degradation of endogenous Abi-1, which led to the formation of a NESH/Abi-3-based WAVE2 complex
GO:1903077 negative regulation of protein localization to plasma membrane
ISS
GO_REF:0000024
ACCEPT
Summary: ISS annotation from mouse ortholog. ABI3 expression reduces WAVE2 translocation to the plasma membrane, as shown in PMID:26428302.
Reason: Well-supported by experimental data. ABI3-containing WAVE2 complexes show reduced membrane translocation compared to ABI1-containing complexes.
Supporting Evidence:
PMID:26428302
the translocation of WAVE2 to the plasma membrane was significantly reduced
GO:0016020 membrane
HDA
PMID:19946888
Defining the membrane proteome of NK cells.
ACCEPT
Summary: HDA annotation from a study defining the membrane proteome of NK cells. ABI3 was detected in the membrane fraction by proteomics.
Reason: ABI3 as a WRC component can associate with membranes, particularly at the leading edge where it colocalizes with PAK2. Detection in membrane proteome of NK cells is consistent with this.
GO:0005737 cytoplasm
IDA
GO_REF:0000054
ACCEPT
Summary: IDA annotation from LIFEdb based on intracellular localization of expressed fusion proteins in living cells. Consistent with UniProt subcellular location annotation.
Reason: Cytoplasmic localization is well-established for ABI3. Supported by multiple independent evidence sources.
GO:0018108 peptidyl-tyrosine phosphorylation
IDA NOT
PMID:17101133
NESH (Abi-3) is present in the Abi/WAVE complex but does not...
ACCEPT
Summary: CORRECT negative annotation. PMID:17101133 explicitly tested and showed that "NESH (Abi-3) had no such effect" on promoting c-Abl-mediated phosphorylation, unlike Abi-1 and Abi-2 which do promote this activity. This negative annotation correctly captures that ABI3/NESH does NOT participate in peptidyl-tyrosine phosphorylation processes.
Reason: Important negative annotation that distinguishes ABI3 from its paralogs ABI1 and ABI2. PMID:17101133 directly tested and demonstrated this difference.
Supporting Evidence:
PMID:17101133
Although Abi-2, like Abi-1, promoted the c-Abl-mediated phosphorylation of Mena and WAVE2, NESH (Abi-3) had no such effect. This difference was likely due to their binding abilities as to c-Abl
GO:0030027 lamellipodium
IDA
PMID:17101133
NESH (Abi-3) is present in the Abi/WAVE complex but does not...
ACCEPT
Summary: IDA annotation from PMID:17101133. ABI3 was shown to be present in the Abi/WAVE complex which localizes to lamellipodia where it regulates Rac-dependent actin polymerization.
Reason: Direct experimental evidence supports lamellipodium localization of ABI3 as part of the WAVE complex.
Supporting Evidence:
PMID:17101133
Immunoprecipitation revealed that NESH (Abi-3) is present in the Abi/WAVE complex
GO:0030334 regulation of cell migration
IDA
PMID:11956071
Forced expression of NESH suppresses motility and metastatic...
ACCEPT
Summary: IDA annotation from PMID:11956071 showing forced NESH/ABI3 expression suppresses cell motility. NESH transfectants showed marked reduction in motility and reduced tumor metastatic potential in vivo.
Reason: Core function. One of the earliest and best-characterized biological roles of ABI3. Direct experimental demonstration of cell migration regulation.
Supporting Evidence:
PMID:11956071
every clone of NESH transfectants caused a marked reduction in motility, although the clones exhibited no significant differences in intrinsic cell growth compared with the control cells in vitro. The NESH transfectants also exhibited significant reduction in tumor metastatic potential in vivo
GO:0005737 cytoplasm
NAS
PMID:11956071
Forced expression of NESH suppresses motility and metastatic...
ACCEPT
Summary: NAS annotation for cytoplasmic localization from PMID:11956071. The paper describes NESH as an intracellular SH3 adapter protein.
Reason: Consistent with other evidence for cytoplasmic localization. The paper describes cytoplasmic distribution and colocalization with PAK2 at the leading edge of cells.
Supporting Evidence:
PMID:11956071
The SH3 domain of NESH seems to interact with p21-activated kinase (PAK), which is involved in regulation of cell motility

Core Functions

Component of the WAVE regulatory complex (WRC/SCAR complex), occupying the Abi subunit position. ABI3 forms a heteropentameric complex with WAVE2, CYFIP1, NAP1, and BRK1 that couples upstream signals (Rac, Arf GTPases) to Arp2/3-mediated actin nucleation and polymerization.

Molecular Function:
signaling adaptor activity
Directly Involved In:
Cellular Locations:
Supporting Evidence:
  • PMID:17101133
    Immunoprecipitation revealed that NESH (Abi-3) is present in the Abi/WAVE complex. Our results suggest that NESH (Abi-3), like Abi-1 and Abi-2, is a component of the Abi/WAVE complex
  • PMID:26428302
    The expression of NESH/Abi-3 caused degradation of endogenous Abi-1, which led to the formation of a NESH/Abi-3-based WAVE2 complex

Modulates actin-dependent cell migration. ABI3 expression suppresses cell motility and metastatic dissemination. The ABI3-containing WAVE2 complex is functionally distinct from the ABI1-containing complex, reducing WAVE2 translocation to the plasma membrane and impairing lamellipodium formation. ABI3 also interacts with PAK and IRSp53 via its SH3 domain to regulate migration-related signaling.

Molecular Function:
signaling adaptor activity
Directly Involved In:
Supporting Evidence:
  • PMID:11956071
    every clone of NESH transfectants caused a marked reduction in motility, although the clones exhibited no significant differences in intrinsic cell growth compared with the control cells in vitro
  • PMID:26428302
    the translocation of WAVE2 to the plasma membrane was significantly reduced and the formation of peripheral lamellipodial structures was disturbed

Negative regulation of lamellipodium assembly and membrane ruffling. ABI3-based WAVE2 complexes specifically impair the formation of peripheral lamellipodial structures, distinguishing ABI3 from ABI1 and ABI2 in terms of protrusion type regulation.

Supporting Evidence:
  • PMID:26428302
    the NESH/Abi-3-based WAVE2 complex was unable to help produce lamellipodial protrusions

References

Manual transfer of experimentally-verified manual GO annotation data to orthologs by curator judgment of sequence similarity
Annotation inferences using phylogenetic trees
Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping, accompanied by conservative changes to GO terms applied by UniProt
Gene Ontology annotation based on curation of intracellular localizations of expressed fusion proteins in living cells
Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara
Combined Automated Annotation using Multiple IEA Methods
Forced expression of NESH suppresses motility and metastatic dissemination of malignant cells.
  • NESH/ABI3 forced expression suppresses cell motility and metastatic dissemination. NESH interacts with PAK via its SH3 domain and decreases PAK phosphorylation at Thr402.
    "every clone of NESH transfectants caused a marked reduction in motility, although the clones exhibited no significant differences in intrinsic cell growth compared with the control cells in vitro. The NESH transfectants also exhibited significant reduction in tumor metastatic potential in vivo."
Towards a proteome-scale map of the human protein-protein interaction network.
NESH (Abi-3) is present in the Abi/WAVE complex but does not promote c-Abl-mediated phosphorylation.
  • ABI3/NESH is present in the Abi/WAVE complex by immunoprecipitation but does not bind c-Abl and does not promote c-Abl-mediated phosphorylation of Mena or WAVE2, distinguishing it from ABI1 and ABI2.
    "Immunoprecipitation revealed that NESH (Abi-3) is present in the Abi/WAVE complex. Our results suggest that NESH (Abi-3), like Abi-1 and Abi-2, is a component of the Abi/WAVE complex, but likely plays a different role in the regulation of c-Abl."
Insulin receptor substrate protein 53 (IRSp53) as a binding partner of antimetastasis molecule NESH, a member of Abelson interactor protein family.
  • IRSp53 identified as a binding partner of NESH/ABI3. IRSp53 is involved in PDGF-stimulated membrane ruffling.
    "Insulin receptor substrate protein 53 (IRSp53) as a binding partner of antimetastasis molecule NESH, a member of Abelson interactor protein family."
An empirical framework for binary interactome mapping.
Defining the membrane proteome of NK cells.
  • ABI3 detected in the membrane proteome of NK cells by high-throughput proteomics.
    "The present study was initiated to define the composition of the membrane proteome of the Natural Killer (NK) like cell line YTS"
ABI3 ectopic expression reduces in vitro and in vivo cell growth properties while inducing senescence.
  • ABI3 re-expression in thyroid and colon carcinoma cells reduces transforming activity, inhibits anchorage-independent growth, suppresses in vivo tumor formation, and induces cellular senescence via p21WAF1 upregulation and ERK phosphorylation reduction.
Next-generation sequencing to generate interactome datasets.
A proteome-scale map of the human interactome network.
The NESH/Abi-3-based WAVE2 complex is functionally distinct from the Abi-1-based WAVE2 complex.
  • ABI3 expression in NIH3T3 cells causes degradation of endogenous ABI1 and formation of a distinct ABI3-based WAVE2 complex that reduces WAVE2 translocation to the plasma membrane and impairs lamellipodial protrusions. In v-src transformed cells, ABI3 promotes invadopodia formation under certain conditions.
An inter-species protein-protein interaction network across vast evolutionary distance.
An interactome perturbation framework prioritizes damaging missense mutations for developmental disorders.
A reference map of the human binary protein interactome.
Multimodal cell maps as a foundation for structural and functional genomics.

Suggested Questions for Experts

Q: Does ABI3 directly bind actin filaments, or does it solely function as an adaptor within the WRC?

Q: Is ABI3 expressed in neurons as well as microglia, and does it have neuron-specific functions?

Q: How does the S209F Alzheimer disease risk variant affect ABI3 incorporation into the WRC and microglial function?

Q: What is the precise mechanism by which ABI3 phosphorylation at S213/S216/S342 regulates its WRC incorporation?

Suggested Experiments

Experiment: Direct actin filament binding assays (e.g., co-sedimentation) with purified ABI3 protein to test whether ABI3 has intrinsic actin-binding activity

Experiment: Single-cell RNA-seq or spatial transcriptomics to clarify ABI3 expression across brain cell types in human tissue

Experiment: In vitro WRC reconstitution with ABI3 vs ABI1 to measure differences in Arp2/3 activation kinetics

Experiment: CRISPR knock-in of the S209F variant in human iPSC-derived microglia to assess effects on migration, phagocytosis, and WRC dynamics

πŸ“š Additional Documentation

Deep Research Falcon

(ABI3-deep-research-falcon.md)

provider: falcon
model: Edison Scientific Literature
cached: false
start_time: '2026-03-06T02:46:49.833183'
end_time: '2026-03-06T03:00:25.028144'
duration_seconds: 815.2
template_file: templates/gene_research_go_focused.md
template_variables:
organism: human
gene_id: ABI3
gene_symbol: ABI3
uniprot_accession: Q9P2A4
protein_description: 'RecName: Full=ABI gene family member 3; AltName: Full=New
molecule including SH3; Short=Nesh;'
gene_info: Name=ABI3; Synonyms=NESH;
organism_full: Homo sapiens (Human).
protein_family: Belongs to the ABI family. .
protein_domains: ABI. (IPR028457); ABI3_SH3. (IPR028455); Abl-interactor_HHR_dom.
(IPR012849); SH3-like_dom_sf. (IPR036028); SH3_domain. (IPR001452)
provider_config:
timeout: 600
max_retries: 3
parameters:
allowed_domains: []
temperature: 0.1
citation_count: 27


Question

Gene Research for Functional Annotation

⚠️ CRITICAL: Gene/Protein Identification Context

BEFORE YOU BEGIN RESEARCH: You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

Target Gene/Protein Identity (from UniProt):

  • UniProt Accession: Q9P2A4
  • Protein Description: RecName: Full=ABI gene family member 3; AltName: Full=New molecule including SH3; Short=Nesh;
  • Gene Information: Name=ABI3; Synonyms=NESH;
  • Organism (full): Homo sapiens (Human).
  • Protein Family: Belongs to the ABI family. .
  • Key Domains: ABI. (IPR028457); ABI3_SH3. (IPR028455); Abl-interactor_HHR_dom. (IPR012849); SH3-like_dom_sf. (IPR036028); SH3_domain. (IPR001452)

MANDATORY VERIFICATION STEPS:

  1. Check if the gene symbol "ABI3" matches the protein description above
  2. Verify the organism is correct: Homo sapiens (Human).
  3. Check if protein family/domains align with what you find in literature
  4. If you find literature for a DIFFERENT gene with the same or similar symbol, STOP

If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE. Instead:
- State clearly: "The gene symbol 'ABI3' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

Research Target:

Please provide a comprehensive research report on the gene ABI3 (gene ID: ABI3, UniProt: Q9P2A4) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Output

Question: You are an expert researcher providing comprehensive, well-cited information.

Provide detailed information focusing on:
1. Key concepts and definitions with current understanding
2. Recent developments and latest research (prioritize 2023-2024 sources)
3. Current applications and real-world implementations
4. Expert opinions and analysis from authoritative sources
5. Relevant statistics and data from recent studies

Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.
Always prioritize recent, authoritative sources and provide specific citations for all major claims.

Gene Research for Functional Annotation

⚠️ CRITICAL: Gene/Protein Identification Context

BEFORE YOU BEGIN RESEARCH: You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.

Target Gene/Protein Identity (from UniProt):

  • UniProt Accession: Q9P2A4
  • Protein Description: RecName: Full=ABI gene family member 3; AltName: Full=New molecule including SH3; Short=Nesh;
  • Gene Information: Name=ABI3; Synonyms=NESH;
  • Organism (full): Homo sapiens (Human).
  • Protein Family: Belongs to the ABI family. .
  • Key Domains: ABI. (IPR028457); ABI3_SH3. (IPR028455); Abl-interactor_HHR_dom. (IPR012849); SH3-like_dom_sf. (IPR036028); SH3_domain. (IPR001452)

MANDATORY VERIFICATION STEPS:

  1. Check if the gene symbol "ABI3" matches the protein description above
  2. Verify the organism is correct: Homo sapiens (Human).
  3. Check if protein family/domains align with what you find in literature
  4. If you find literature for a DIFFERENT gene with the same or similar symbol, STOP

If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:

DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE. Instead:
- State clearly: "The gene symbol 'ABI3' is ambiguous or literature is limited for this specific protein"
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")
- Describe the protein based ONLY on the UniProt information provided above
- Suggest that the protein function can be inferred from domain/family information

Research Target:

Please provide a comprehensive research report on the gene ABI3 (gene ID: ABI3, UniProt: Q9P2A4) in human.

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Research Report: Human ABI3 / NESH (UniProt Q9P2A4) β€” Functional Annotation

0) Target verification (critical identity checks)

The literature reviewed matches the UniProt target Q9P2A4: ABI gene family member 3 (gene ABI3), also known as NESH (β€œNEw molecule including SH3”), in Homo sapiens. ABI3 is consistently described as an ABI-family adaptor protein containing a C-terminal SH3 domain and proline-rich regions, and as an Abi subunit option within the WAVE regulatory complex (WRC) (sekino2015theneshabi3basedwave2 pages 1-2, um2023fat10inducescancer pages 1-2, kim2025thewavecomplex pages 11-12).

1) Key concepts and definitions (current understanding)

1.1 ABI3 is an ABI-family adaptor that participates in actin regulation via the WAVE regulatory complex

The ABI (Abl interactor) family (ABI1/ABI2/ABI3) forms the Abi subunit of the heteropentameric WAVE regulatory complex (WRC), which couples upstream membrane signals to Arp2/3-mediated actin nucleation. In this complex, ABI proteins are interchangeable family members in principle, but individual ABI paralogs can confer distinct functional properties. Reviews summarize WRC as a five-subunit complex (CYFIP–NCKAP–ABI–BRK1–WAVE) whose activation (e.g., by small GTPases) enables Arp2/3 activation and actin polymerization (han2023orchestrationofsynaptic pages 1-2). A WRC schematic including ABI1/2/3 domain architecture and an activation model (Rac/Arfβ†’Arp2/3) is shown in Han & Ko 2023 (Fig. 1) (han2023orchestrationofsynaptic media f4951c09).

1.2 Domain architecture and paralog distinction

A detailed experimental description of ABI family architecture notes shared regions including an N-terminal WAVE-binding interface, proline-rich regions, and a C-terminal SH3 domain. Importantly, ABI3/NESH is described as present in WAVE2-containing complexes but does not bind c-Abl nor promote c-Abl-mediated WAVE2 phosphorylation, distinguishing it from ABI1/ABI2 functions in certain contexts (sekino2015theneshabi3basedwave2 pages 1-2).

2) Molecular function, pathways, and regulation

2.1 Physical membership in the WRC and interaction partners

Biochemical evidence supports ABI3 as a bona fide WRC-associated protein. In a thyroid cancer cell context, immunoprecipitation–mass spectrometry identified WRC components (WAVE2, CYFIP1, NAP1) among ABI3 partners (moraes2017abi3acomponent pages 1-2, moraes2017abi3acomponent pages 2-5). This is consistent with WRC reviews placing ABI paralogs (including ABI3/NESH) as part of the Abi-position in the complex (rottner2021waveregulatorycomplex pages 1-2, han2023orchestrationofsynaptic pages 1-2).

2.2 ABI3-containing WAVE2 complexes are functionally distinct from ABI1-containing complexes

Sekino et al. (2015) provide direct functional comparisons:
- Ectopic ABI3/NESH expression in NIH3T3 cells reduces WAVE2 translocation to the plasma membrane and disrupts peripheral lamellipodia formation during fibronectin stimulation (sekino2015theneshabi3basedwave2 pages 1-2).
- ABI3/NESH does not support c-Abl-dependent tyrosine phosphorylation of WAVE2, whereas ABI1 does (sekino2015theneshabi3basedwave2 pages 8-10, sekino2015theneshabi3basedwave2 pages 1-2).
- In v-src–transformed cells, ABI3/NESH is linked to invadopodia-related phenotypes (ventral protrusions) and shows distinct responses to Abl inhibition/knockdown, implying context-dependent roles in ventral actin structures rather than lamellipodial protrusions (sekino2015theneshabi3basedwave2 pages 8-10, sekino2015theneshabi3basedwave2 pages 5-8).

These findings support a model where ABI3 modulates the mode of actin-based protrusion and WRC localization/activation in a way that differs from ABI1.

2.3 Regulation by phosphorylation and PI3K–AKT signaling

Multiple lines of evidence indicate ABI3 is regulated by phosphorylation:
- ABI3 is detected in phosphorylated and non-phosphorylated forms, and phosphatase treatment collapses the upper band, consistent with phosphorylation (moraes2017abi3acomponent pages 1-2).
- Moraes et al. (2017) propose ABI3 as a downstream mediator of PI3K/AKT signaling: forced ABI3 expression decreased pAKT and pGSK3Ξ², and an AKT-predicted site (S342) plus pharmacologic PI3K inhibition and mutational analysis support that the non-phosphorylated ABI3 preferentially associates with WRC (moraes2017abi3acomponent pages 1-2).
- Satoh et al. (2017) summarize that phosphorylated ABI3 is inactive and excluded from WRC, while the non-phosphorylated form is preferentially incorporated, linking phosphorylation state to WRC assembly (satoh2017microgliaexpressabi3 pages 4-6).

2.4 Recent mechanistic development (2023): FAT10 stabilizes phosphorylated ABI3 to promote migration

Um et al. (2023) report that ABI3 stability can be controlled by FAT10, with higher affinity for phosphorylated ABI3. They identify S213 and S216 as key phosphorylation sites via phospho-dead and phospho-mimetic mutants; cycloheximide chase assays (100 ΞΌM CHX, 0–8 h) and statistical testing (one-way ANOVA with Tukey; p < 0.01–0.001) support preferential stabilization of phosphorylated ABI3 by FAT10 and increased cancer cell migration in scratch assays (um2023fat10inducescancer pages 6-7). This provides a concrete mechanism linking ABI3 phosphorylation state to protein turnover and migratory phenotypes.

3) Cellular localization and biological roles (cellular context)

3.1 Subcellular localization in cell models

In vitro expression studies suggest full-length ABI3 can show dispersed punctate cytosolic localization, while certain splice isoforms (notably exon-6–lacking variants) can form extensive aggregates in transfected cells including microglial lines (turner2022identificationandquantitation pages 1-2).

3.2 Microglia: expression, morphology, surveillance, and activation markers

ABI3 is strongly implicated as a microglia-enriched gene:
- Human brain and mouse scRNAseq evidence indicates ABI3 is primarily expressed by microglia, including disease-associated microglia in AD mouse models (turner2022identificationandquantitation pages 1-2).
- Immunohistochemistry in human brain shows ABI3 immunoreactivity largely in a subset of microglia across control, AD, and Nasu–Hakola disease samples; morphometric analysis did not detect significant group differences in ABI3-labeled microglial area (grey matter p=0.8689; white matter p=0.8237) (satoh2017microgliaexpressabi3 pages 4-6).
- In cultured human microglia (HMO6), TGFΞ²1 significantly elevates ABI3 mRNA (p=0.0001), whereas LPS/IFNΞ³/IL-4/IL-13 do not, suggesting context-specific transcriptional regulation (satoh2017microgliaexpressabi3 pages 4-6).

In vivo functional imaging and morphometry (mouse) supports a role in microglial shape and tissue surveillance:
- Abi3 loss reduces microglial dynamic surveillance area over 45 minutes to ~52–53% in KO vs ~73–75% in WT (two-photon imaging) (simonazzi2021abi3regulatesmicroglial pages 5-8).
- Abi3-KO microglia display altered ramification and distribution metrics (e.g., reduced Sholl intersections; altered branching points) and increased CD68 within microglia, consistent with altered activation/phagolysosomal state (simonazzi2021abi3regulatesmicroglial pages 5-8).

4) Disease relevance with emphasis on Alzheimer’s disease (AD)

4.1 Human genetics: ABI3 S209F is a replicated risk variant

Several sources report that ABI3 rare coding variant rs616338 (S209F) increases late-onset AD risk with effect size OR β‰ˆ 1.43 (and very strong association p-values in large studies). Reported values include OR=1.43, p=4.5Γ—10βˆ’10, MAFβ‰ˆ0.008 (ibanez2022deletionofabi3gngt2 pages 1-2), and similarly P=4.56Γ—10βˆ’10, OR=1.43 (karahan2021deletionofabi3 pages 1-2). These effect sizes also appear in isoform-focused analyses that contextualize ABI3 expression and splicing in AD neuropathology (turner2022identificationandquantitation pages 1-2).

4.2 Mouse model evidence: ABI3 influences amyloid and tau pathologies, microglial clustering, and synaptic physiology

Results across models suggest ABI3 function modulates microglial behavior and downstream neuropathology, though directionality may depend on model, age, and whether the knockout affects neighboring genes.

Increased amyloid pathology with Abi3-locus deletion (5XFAD)
Karahan et al. (Science Advances, 2021) report Abi3 locus deletion in 5XFAD increases amyloid burden and reduces microglial clustering near plaques. Quantitatively, male Abi3+/βˆ’ and Abi3βˆ’/βˆ’ cortices show insoluble AΞ²40 increases by ~1.4- and 2.1-fold and soluble AΞ²42 increases by ~1.4- and 1.6-fold vs Abi3+/+; female Abi3βˆ’/βˆ’ cortices show insoluble AΞ²40 and AΞ²42 increases by ~2.2- and 1.5-fold (karahan2021deletionofabi3 pages 1-2).

Early-stage amyloid increase (5XFAD; 4.5 months)
A 2023 report analyzing 4.5-month-old 5XFAD females finds Abi3 locus deletion increases AΞ² plaque deposition and elevates cytokine protein levels, with transcriptomic shifts in immune genes (Tyrobp, Fcer1g, C1qa) but no significant change in microgliosis/astrogliosis at that time point (karahan2023theeffectof pages 1-2).

Reduced amyloid pathology in TgCRND8 after ABI3-GNGT2 locus deletion (preprint; 2023)
A bioRxiv preprint reports that deletion of ABI3 (using a KO that also affects GNGT2) in TgCRND8 mice reduces plaque pathology. Quantitatively (small n), plaque number and area measures are significantly reduced (e.g., plaque number cortex Pβ‰ˆ0.0011; hippocampus P<0.0001; plaque area P<0.0001; plaque density P<0.0001; Welch’s t-tests; Tg WT N=3 vs Tg KO n=2) (ghaffari2023abi3deletionin pages 7-9). Microglial counts within 20 ΞΌm of plaques are lower in KO compared with Tg WT (Pβ‰ˆ0.0021) (ghaffari2023abi3deletionin pages 7-9). The authors note attribution is complicated because this KO impacts GNGT2 as well (ghaffari2023abi3deletionin pages 1-4, ghaffari2023abi3deletionin pages 7-9).

Amyloid vs tau divergence with Abi3-Gngt2 deletion (2022)
Ibanez et al. (2022) highlight that Abi3-Gngt2 deletion can reduce AΞ² deposition in APP models while exacerbating tauopathy when tau is introduced (pro-aggregant tau AAV), emphasizing that immune pathway targeting can have opposing effects on amyloid vs tau (ibanez2022deletionofabi3gngt2 pages 1-2, ibanez2022deletionofabi3gngt2 pages 17-22).

A coherent mechanistic theme across sources is that ABI3, as a WRC subunit option, affects actin-dependent microglial behaviors (migration, process dynamics, tissue surveillance), which can change plaque engagement and inflammatory programs (karahan2021deletionofabi3 pages 1-2, simonazzi2021abi3regulatesmicroglial pages 5-8). Importantly, ABI3 phosphorylation state can regulate its incorporation into WRC and potentially its effect on actin signaling (moraes2017abi3acomponent pages 1-2, satoh2017microgliaexpressabi3 pages 4-6).

4.4 Authoritative target–disease association (Open Targets)

Open Targets lists ABI3 (ENSG00000108798) as associated with Alzheimer disease (score ~0.43) and late-onset Alzheimer’s disease (score ~0.32), with multiple literature evidences linked (Open Targets evidence list) (sekino2015theneshabi3basedwave2 pages 1-2). This supports ABI3 as a curated AD-associated microglial gene, consistent with the genetic association and functional studies above.

5) Recent developments and latest research (prioritizing 2023–2024)

5.1 2023: ABI3 phosphorylation control and migration (FAT10)

The FAT10–ABI3 study (2023) provides a newer regulatory mechanism: ABI3 phosphorylation at S213/S216 and stabilization of phosphorylated ABI3 by FAT10 drives migration phenotypes (um2023fat10inducescancer pages 6-7). While performed in cancer cell models, it advances understanding of how ABI3 post-translational regulation can modulate actin-related behaviors.

5.2 2023: Early-stage AD progression effects in 5XFAD

The 2023 Frontiers in Immunology report adds stage-specific evidence that ABI3 loss can increase AΞ² plaque deposition and inflammatory cytokine levels early in amyloid pathology, with immune gene expression alterations (karahan2023theeffectof pages 1-2).

5.3 2023: Conflicting amyloid outcomes and model dependence

The 2023 TgCRND8 preprint reports reduced plaque pathology with ABI3-GNGT2 locus deletion, highlighting model dependence and the need to control for the overlapping GNGT2 locus and small cohort sizes (ghaffari2023abi3deletionin pages 1-4, ghaffari2023abi3deletionin pages 7-9).

6) Current applications and real-world implementations

6.1 Patient stratification and genetic interpretation

Given replicated genetic effect sizes for S209F (OR~1.43), ABI3 variants are suitable for inclusion in genetic risk models or research stratification of cohorts, particularly in studies focused on microglial pathways and late-onset AD genetics (ibanez2022deletionofabi3gngt2 pages 1-2, karahan2021deletionofabi3 pages 1-2).

6.2 Biomarker-oriented findings (research stage)

Human brain data indicate ABI3 expression increases with AD neuropathology and is primarily microglial, and ABI3 isoform variation (exon 6) can produce aggregation-prone proteins in vitro; these features motivate ABI3 as a candidate microglia-related molecular biomarker, though clinical implementation is not established in the retrieved sources (turner2022identificationandquantitation pages 1-2).

6.3 Therapeutic implications (research stage; caution required)

Mouse studies suggest that perturbing ABI3/ABI3-locus function can alter amyloid vs tau phenotypes in opposite directions, implying that interventions affecting ABI3-related microglial programs could have unpredictable net effects across AD endophenotypes (amyloid vs tau) (ibanez2022deletionofabi3gngt2 pages 1-2, ibanez2022deletionofabi3gngt2 pages 17-22). This supports a cautious β€œmechanism-first” approach rather than direct target inhibition/activation without phenotype stratification.

7) Expert opinions / authoritative synthesis

Reviews of WRC biology and neuronal function emphasize that WRC is essential for actin regulation and that ABI family members (including ABI3) function as part of the WRC subunit architecture (han2023orchestrationofsynaptic pages 1-2). WRC reviews and primary studies collectively support that differences among ABI paralogs can alter complex localization and downstream protrusive structures (lamellipodia vs ventral protrusions), providing a plausible mechanistic bridge from ABI3 genetics to microglial motility and plaque engagement in AD (sekino2015theneshabi3basedwave2 pages 1-2, simonazzi2021abi3regulatesmicroglial pages 5-8).

8) Key statistics and data points (from recent and foundational studies)

  • AD genetic risk (ABI3 S209F / rs616338): OR β‰ˆ 1.43; p-values reported as 4.5Γ—10βˆ’10 and 4.56Γ—10βˆ’10; MAF β‰ˆ 0.008 (ibanez2022deletionofabi3gngt2 pages 1-2, karahan2021deletionofabi3 pages 1-2).
  • 5XFAD amyloid increases with Abi3-locus deletion: insoluble AΞ²40 up to 2.1-fold (male Abi3βˆ’/βˆ’), soluble AΞ²42 up to 1.6-fold, and female Abi3βˆ’/βˆ’ insoluble AΞ²40 2.2-fold (karahan2021deletionofabi3 pages 1-2).
  • Microglial surveillance deficit in Abi3 KO: area surveyed over 45 min reduced to ~52–53% in KO vs ~73–75% in WT (simonazzi2021abi3regulatesmicroglial pages 5-8).
  • Human microglia gene regulation: TGFΞ²1 increases ABI3 mRNA in HMO6 cells (p=0.0001) (satoh2017microgliaexpressabi3 pages 4-6).
  • TgCRND8 KO (ABI3-GNGT2) plaque reductions (preprint, small n): plaque number and pathology measures reduced with P-values including P<0.0001 for several plaque metrics; microglia around plaques reduced (Pβ‰ˆ0.0021) (ghaffari2023abi3deletionin pages 7-9).
  • Phosphoregulation/migration (2023 cancer model): FAT10 preferentially stabilizes phosphorylated ABI3; CHX chase and migration assays show statistical significance (p<0.01–0.001) (um2023fat10inducescancer pages 6-7).

9) Limitations and open questions

  1. Complex attribution in mouse knockouts: Some Abi3 KO lines disrupt overlapping Gngt2, complicating causal attribution to ABI3 alone (ibanez2022deletionofabi3gngt2 pages 1-2, ghaffari2023abi3deletionin pages 1-4).
  2. Model- and stage-dependence: ABI3 perturbation can increase amyloid pathology in some models (5XFAD) yet reduce plaques in others (TgCRND8 preprint), and can have divergent effects on AΞ² vs tau (karahan2021deletionofabi3 pages 1-2, ghaffari2023abi3deletionin pages 7-9, ibanez2022deletionofabi3gngt2 pages 17-22).
  3. Direct biochemical function: ABI3 is an adaptor rather than an enzyme/transporter; its β€œprimary function” is best defined as modulating WRC composition/localization and actin-dependent cellular behaviors rather than catalysis. Whether ABI3 directly inhibits or tunes Arp2/3 activation is context-dependent; some studies describe ABI3 as inhibitory for WAVE-mediated actin polymerization, but direct in vitro reconstitution measures were not available in the retrieved excerpts (turner2022identificationandquantitation pages 1-2, sekino2015theneshabi3basedwave2 pages 1-2).

Summary

Human ABI3/NESH (Q9P2A4) is a microglia-enriched ABI-family adaptor that participates in the WAVE regulatory complex to regulate actin cytoskeleton–dependent behaviors. ABI3-containing WAVE2 complexes differ from ABI1-containing complexes in c-Abl binding, WAVE2 phosphorylation, and protrusion phenotypes, providing a mechanistic basis for effects on cell migration and microglial plaque engagement. ABI3 is regulated by phosphorylation downstream of PI3K–AKT, and new 2023 evidence links phosphorylated ABI3 stabilization to FAT10-driven migration. In AD, ABI3 harbors a replicated risk variant (S209F, OR~1.43) and in vivo models support roles in microglial surveillance and modulation of amyloid/tau pathology, albeit with model- and locus-dependent differences (karahan2021deletionofabi3 pages 1-2, simonazzi2021abi3regulatesmicroglial pages 5-8, ibanez2022deletionofabi3gngt2 pages 1-2).

Key URLs (from cited sources)

  • Sekino et al., 2015-10: https://doi.org/10.1186/s12964-015-0119-5 (sekino2015theneshabi3basedwave2 pages 1-2)
  • Moraes et al., 2017-06: https://doi.org/10.18632/oncotarget.18840 (moraes2017abi3acomponent pages 1-2)
  • Satoh et al., 2017-11: https://doi.org/10.5582/irdr.2017.01073 (satoh2017microgliaexpressabi3 pages 4-6)
  • Karahan et al., 2021-11: https://doi.org/10.1126/sciadv.abe3954 (karahan2021deletionofabi3 pages 1-2)
  • Ibanez et al., 2022-07: https://doi.org/10.1186/s13195-022-01044-1 (ibanez2022deletionofabi3gngt2 pages 1-2)
  • Turner et al., 2022-09: https://doi.org/10.3390/genes13091607 (turner2022identificationandquantitation pages 1-2)
  • Um et al., 2023-03: https://doi.org/10.1080/19768354.2023.2186486 (um2023fat10inducescancer pages 6-7)
  • Karahan et al., 2023-02: https://doi.org/10.3389/fimmu.2023.1102530 (karahan2023theeffectof pages 1-2)
  • Ghaffari et al., 2023-10 (preprint): https://doi.org/10.1101/2023.10.05.560956 (ghaffari2023abi3deletionin pages 7-9)

References

  1. (sekino2015theneshabi3basedwave2 pages 1-2): Saki Sekino, Yuriko Kashiwagi, Hitoshi Kanazawa, Kazuki Takada, Takashi Baba, Seiichi Sato, Hiroki Inoue, Masaki Kojima, and Katsuko Tani. The nesh/abi-3-based wave2 complex is functionally distinct from the abi-1-based wave2 complex. Cell Communication and Signaling : CCS, Oct 2015. URL: https://doi.org/10.1186/s12964-015-0119-5, doi:10.1186/s12964-015-0119-5. This article has 43 citations.

  2. (um2023fat10inducescancer pages 1-2): Hyojin Um, Hoim Jeong, Beomgu Lee, Yerin Kim, Jihyeon Lee, Jong Seong Roh, Seung-Geun Lee, Hae Ryoun Park, William H. Robinson, and Dong Hyun Sohn. Fat10 induces cancer cell migration by stabilizing phosphorylated abi3/nesh. Animal Cells and Systems, 27:53-60, Mar 2023. URL: https://doi.org/10.1080/19768354.2023.2186486, doi:10.1080/19768354.2023.2186486. This article has 9 citations and is from a peer-reviewed journal.

  3. (kim2025thewavecomplex pages 11-12): Hyung-Goo Kim, Clara Berdasco, Angus C. Nairn, and Yong Kim. The wave complex in developmental and adulthood brain disorders. Experimental & Molecular Medicine, 57:13-29, Jan 2025. URL: https://doi.org/10.1038/s12276-024-01386-w, doi:10.1038/s12276-024-01386-w. This article has 3 citations and is from a peer-reviewed journal.

  4. (han2023orchestrationofsynaptic pages 1-2): Kyung Ah Han and Jaewon Ko. Orchestration of synaptic functions by wave regulatory complex-mediated actin reorganization. Experimental & Molecular Medicine, 55:1065-1075, Jun 2023. URL: https://doi.org/10.1038/s12276-023-01004-1, doi:10.1038/s12276-023-01004-1. This article has 31 citations and is from a peer-reviewed journal.

  5. (han2023orchestrationofsynaptic media f4951c09): Kyung Ah Han and Jaewon Ko. Orchestration of synaptic functions by wave regulatory complex-mediated actin reorganization. Experimental & Molecular Medicine, 55:1065-1075, Jun 2023. URL: https://doi.org/10.1038/s12276-023-01004-1, doi:10.1038/s12276-023-01004-1. This article has 31 citations and is from a peer-reviewed journal.

  6. (moraes2017abi3acomponent pages 1-2): Lais Moraes, Nilson I.T. Zanchin, and Janete M. Cerutti. Abi3, a component of the wave2 complex, is potentially regulated by pi3k/akt pathway. Oncotarget, 8:67769-67781, Jun 2017. URL: https://doi.org/10.18632/oncotarget.18840, doi:10.18632/oncotarget.18840. This article has 26 citations.

  7. (moraes2017abi3acomponent pages 2-5): Lais Moraes, Nilson I.T. Zanchin, and Janete M. Cerutti. Abi3, a component of the wave2 complex, is potentially regulated by pi3k/akt pathway. Oncotarget, 8:67769-67781, Jun 2017. URL: https://doi.org/10.18632/oncotarget.18840, doi:10.18632/oncotarget.18840. This article has 26 citations.

  8. (rottner2021waveregulatorycomplex pages 1-2): Klemens Rottner, Theresia E.B. Stradal, and Baoyu Chen. Wave regulatory complex. Current Biology, 31:R512-R517, May 2021. URL: https://doi.org/10.1016/j.cub.2021.01.086, doi:10.1016/j.cub.2021.01.086. This article has 123 citations and is from a highest quality peer-reviewed journal.

  9. (sekino2015theneshabi3basedwave2 pages 8-10): Saki Sekino, Yuriko Kashiwagi, Hitoshi Kanazawa, Kazuki Takada, Takashi Baba, Seiichi Sato, Hiroki Inoue, Masaki Kojima, and Katsuko Tani. The nesh/abi-3-based wave2 complex is functionally distinct from the abi-1-based wave2 complex. Cell Communication and Signaling : CCS, Oct 2015. URL: https://doi.org/10.1186/s12964-015-0119-5, doi:10.1186/s12964-015-0119-5. This article has 43 citations.

  10. (sekino2015theneshabi3basedwave2 pages 5-8): Saki Sekino, Yuriko Kashiwagi, Hitoshi Kanazawa, Kazuki Takada, Takashi Baba, Seiichi Sato, Hiroki Inoue, Masaki Kojima, and Katsuko Tani. The nesh/abi-3-based wave2 complex is functionally distinct from the abi-1-based wave2 complex. Cell Communication and Signaling : CCS, Oct 2015. URL: https://doi.org/10.1186/s12964-015-0119-5, doi:10.1186/s12964-015-0119-5. This article has 43 citations.

  11. (satoh2017microgliaexpressabi3 pages 4-6): Jun-ichi Satoh, Yoshihiro Kino, Motoaki Yanaizu, Youhei Tosaki, Kenji Sakai, Tsuyoshi Ishida, and Yuko Saito. Microglia express abi3 in the brains of alzheimer's disease and nasu-hakola disease. Intractable & rare diseases research, 6 4:262-268, Nov 2017. URL: https://doi.org/10.5582/irdr.2017.01073, doi:10.5582/irdr.2017.01073. This article has 39 citations.

  12. (um2023fat10inducescancer pages 6-7): Hyojin Um, Hoim Jeong, Beomgu Lee, Yerin Kim, Jihyeon Lee, Jong Seong Roh, Seung-Geun Lee, Hae Ryoun Park, William H. Robinson, and Dong Hyun Sohn. Fat10 induces cancer cell migration by stabilizing phosphorylated abi3/nesh. Animal Cells and Systems, 27:53-60, Mar 2023. URL: https://doi.org/10.1080/19768354.2023.2186486, doi:10.1080/19768354.2023.2186486. This article has 9 citations and is from a peer-reviewed journal.

  13. (turner2022identificationandquantitation pages 1-2): Andrew K. Turner, Benjamin C. Shaw, James F. Simpson, and Steven Estus. Identification and quantitation of novel abi3 isoforms relative to alzheimer’s disease genetics and neuropathology. Genes, 13:1607, Sep 2022. URL: https://doi.org/10.3390/genes13091607, doi:10.3390/genes13091607. This article has 6 citations.

  14. (simonazzi2021abi3regulatesmicroglial pages 5-8): Elena Simonazzi, Ruth E. Jones, Fangli Chen, Adam Ranson, Joshua Stevenson-Hoare, Valentina Escott-Price, Frank Sengpiel, B. Paul Morgan, and Philip R. Taylor. Abi3 regulates microglial ramification and dynamic tissue surveillance in vivo. bioRxiv, Mar 2021. URL: https://doi.org/10.1101/2021.03.19.436147, doi:10.1101/2021.03.19.436147. This article has 3 citations.

  15. (ibanez2022deletionofabi3gngt2 pages 1-2): Kristen R. Ibanez, Karen N. McFarland, Jennifer Phillips, Mariet Allen, Christian B. Lessard, Lillian Zobel, Elsa Gonzalez De La Cruz, Shivani Shah, Quan Vo, Xue Wang, Zachary Quicksall, Daniel Ryu, Cory Funk, NilΓΌfer Ertekin-Taner, Stefan Prokop, Todd E. Golde, and Paramita Chakrabarty. Deletion of abi3/gngt2 influences age-progressive amyloid Ξ² and tau pathologies in distinctive ways. Alzheimer's Research & Therapy, Jul 2022. URL: https://doi.org/10.1186/s13195-022-01044-1, doi:10.1186/s13195-022-01044-1. This article has 22 citations and is from a domain leading peer-reviewed journal.

  16. (karahan2021deletionofabi3 pages 1-2): Hande Karahan, Daniel C. Smith, Byungwook Kim, Luke C. Dabin, Md Mamun Al-Amin, H. R. Sagara Wijeratne, Taylor Pennington, Gonzalo Viana di Prisco, Brianne McCord, Peter Bor-chian Lin, Yuxin Li, Junmin Peng, Adrian L. Oblak, Shaoyou Chu, Brady K. Atwood, and Jungsu Kim. Deletion of abi3 gene locus exacerbates neuropathological features of alzheimer’s disease in a mouse model of aΞ² amyloidosis. Science Advances, Nov 2021. URL: https://doi.org/10.1126/sciadv.abe3954, doi:10.1126/sciadv.abe3954. This article has 58 citations and is from a highest quality peer-reviewed journal.

  17. (karahan2023theeffectof pages 1-2): Hande Karahan, Daniel C. Smith, Byungwook Kim, Brianne McCord, Jordan Mantor, Sutha K. John, Md Mamun Al-Amin, Luke C. Dabin, and Jungsu Kim. The effect of abi3 locus deletion on the progression of alzheimer’s disease-related pathologies. Frontiers in Immunology, Feb 2023. URL: https://doi.org/10.3389/fimmu.2023.1102530, doi:10.3389/fimmu.2023.1102530. This article has 19 citations and is from a peer-reviewed journal.

  18. (ghaffari2023abi3deletionin pages 7-9): Deniz Ghaffari, Jennifer Griffin, and Peter St George-Hyslop. Abi3 deletion in tgcrnd8 mice is associated with reduced amyloid plaque pathology and altered glial response. bioRxiv, Oct 2023. URL: https://doi.org/10.1101/2023.10.05.560956, doi:10.1101/2023.10.05.560956. This article has 1 citations.

  19. (ghaffari2023abi3deletionin pages 1-4): Deniz Ghaffari, Jennifer Griffin, and Peter St George-Hyslop. Abi3 deletion in tgcrnd8 mice is associated with reduced amyloid plaque pathology and altered glial response. bioRxiv, Oct 2023. URL: https://doi.org/10.1101/2023.10.05.560956, doi:10.1101/2023.10.05.560956. This article has 1 citations.

  20. (ibanez2022deletionofabi3gngt2 pages 17-22): Kristen R. Ibanez, Karen N. McFarland, Jennifer Phillips, Mariet Allen, Christian B. Lessard, Lillian Zobel, Elsa Gonzalez De La Cruz, Shivani Shah, Quan Vo, Xue Wang, Zachary Quicksall, Daniel Ryu, Cory Funk, NilΓΌfer Ertekin-Taner, Stefan Prokop, Todd E. Golde, and Paramita Chakrabarty. Deletion of abi3/gngt2 influences age-progressive amyloid Ξ² and tau pathologies in distinctive ways. Alzheimer's Research & Therapy, Jul 2022. URL: https://doi.org/10.1186/s13195-022-01044-1, doi:10.1186/s13195-022-01044-1. This article has 22 citations and is from a domain leading peer-reviewed journal.

Citations

  1. han2023orchestrationofsynaptic pages 1-2
  2. turner2022identificationandquantitation pages 1-2
  3. karahan2023theeffectof pages 1-2
  4. kim2025thewavecomplex pages 11-12
  5. rottner2021waveregulatorycomplex pages 1-2
  6. https://doi.org/10.1186/s12964-015-0119-5
  7. https://doi.org/10.18632/oncotarget.18840
  8. https://doi.org/10.5582/irdr.2017.01073
  9. https://doi.org/10.1126/sciadv.abe3954
  10. https://doi.org/10.1186/s13195-022-01044-1
  11. https://doi.org/10.3390/genes13091607
  12. https://doi.org/10.1080/19768354.2023.2186486
  13. https://doi.org/10.3389/fimmu.2023.1102530
  14. https://doi.org/10.1101/2023.10.05.560956
  15. https://doi.org/10.1186/s12964-015-0119-5,
  16. https://doi.org/10.1080/19768354.2023.2186486,
  17. https://doi.org/10.1038/s12276-024-01386-w,
  18. https://doi.org/10.1038/s12276-023-01004-1,
  19. https://doi.org/10.18632/oncotarget.18840,
  20. https://doi.org/10.1016/j.cub.2021.01.086,
  21. https://doi.org/10.5582/irdr.2017.01073,
  22. https://doi.org/10.3390/genes13091607,
  23. https://doi.org/10.1101/2021.03.19.436147,
  24. https://doi.org/10.1186/s13195-022-01044-1,
  25. https://doi.org/10.1126/sciadv.abe3954,
  26. https://doi.org/10.3389/fimmu.2023.1102530,
  27. https://doi.org/10.1101/2023.10.05.560956,

πŸ“„ View Raw YAML

id: Q9P2A4
gene_symbol: ABI3
product_type: PROTEIN
status: DRAFT
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: >-
  ABI3 (also known as NESH) is a member of the ABI (Abl interactor) family of adaptor proteins.
  It contains an N-terminal WAVE-binding domain, proline-rich regions, and a C-terminal SH3 domain.
  ABI3 functions as a component of the WAVE regulatory complex (WRC), occupying the Abi subunit
  position alongside WAVE2, CYFIP1, NAP1, and BRK1. Unlike its paralogs ABI1 and ABI2, ABI3 does
  not bind c-Abl and does not promote c-Abl-mediated phosphorylation of WAVE2 (PMID:17101133).
  ABI3-containing WAVE2 complexes are functionally distinct from ABI1-based complexes, showing
  reduced WAVE2 translocation to the plasma membrane and impaired lamellipodium formation
  (PMID:26428302). ABI3 is regulated by phosphorylation at S213, S216, and S342, with
  non-phosphorylated ABI3 preferentially incorporated into the WRC. ABI3 is enriched in microglia
  in the brain and is a replicated Alzheimer disease risk gene (S209F variant, OR~1.43). In mouse
  models, Abi3 loss impairs microglial ramification and tissue surveillance. ABI3 also shows
  tumor-suppressive properties when ectopically expressed, suppressing cell motility and metastatic
  dissemination (PMID:11956071) and inducing cellular senescence (PMID:21223585).
existing_annotations:
  - term:
      id: GO:0048858
      label: cell projection morphogenesis
    evidence_type: IBA
    original_reference_id: GO_REF:0000033
    review:
      summary: >-
        IBA annotation based on phylogenetic inference from ABI family orthologs across species.
        ABI3 is a WRC component and the WRC is essential for actin-dependent cell projection
        formation. ABI3-containing WAVE2 complexes influence protrusion formation, though
        ABI3 specifically impairs lamellipodial protrusions while potentially favoring ventral
        protrusions (PMID:26428302). The term 'cell projection morphogenesis' is appropriately
        general for this family-level annotation.
      action: ACCEPT
      reason: >-
        As a WRC component, ABI3 modulates actin-dependent cell projections. The IBA annotation
        at this level of specificity is appropriate given the phylogenetic conservation of this
        function across ABI family members.
      supported_by:
        - reference_id: PMID:26428302
          supporting_text: >-
            the formation of peripheral lamellipodial structures was disturbed, suggesting
            that the NESH/Abi-3-based WAVE2 complex was unable to help produce lamellipodial
            protrusions
  - term:
      id: GO:0001764
      label: neuron migration
    evidence_type: IBA
    original_reference_id: GO_REF:0000033
    review:
      summary: >-
        IBA annotation inferred from orthologs. ABI family members participate in
        neuron migration via actin regulation through the WRC. ABI3 is expressed in the brain,
        particularly in microglia (not neurons primarily), but WRC function in neuron migration
        is well-established for ABI1/ABI2 orthologs.
      action: KEEP_AS_NON_CORE
      reason: >-
        Neuron migration is a conserved function of ABI family members through the WRC.
        However, ABI3 is primarily enriched in microglia rather than neurons in the brain.
        The IBA inference from orthologs is phylogenetically reasonable but this is not
        a core function of ABI3 specifically.
  - term:
      id: GO:0030027
      label: lamellipodium
    evidence_type: IBA
    original_reference_id: GO_REF:0000033
    review:
      summary: >-
        IBA annotation for lamellipodium localization based on phylogenetic inference.
        ABI3 localizes to lamellipodia as shown by IDA evidence in PMID:17101133. This
        is consistent with its role as a WRC component, since the WRC drives
        Arp2/3-dependent actin polymerization at the leading edge.
      action: ACCEPT
      reason: >-
        Supported by direct experimental evidence (IDA from PMID:17101133) and consistent
        with ABI3 function as a WRC component. Lamellipodium localization is a core
        aspect of ABI3 biology.
      supported_by:
        - reference_id: PMID:17101133
          supporting_text: >-
            Immunoprecipitation revealed that NESH (Abi-3) is present in the Abi/WAVE complex
  - term:
      id: GO:0031209
      label: SCAR complex
    evidence_type: IBA
    original_reference_id: GO_REF:0000033
    review:
      summary: >-
        IBA annotation for SCAR/WAVE complex membership. This is very well supported
        by multiple IDA studies (PMID:17101133, PMID:26428302) and IP-MS data
        (Moraes et al. 2017). ABI3 is a bona fide component of the WAVE regulatory
        complex, occupying the Abi subunit position.
      action: ACCEPT
      reason: >-
        Core function of ABI3. Membership in the SCAR/WAVE complex is the defining
        biochemical role of ABI3. Strongly supported by multiple independent experimental
        studies.
      supported_by:
        - reference_id: PMID:17101133
          supporting_text: >-
            Immunoprecipitation revealed that NESH (Abi-3) is present in the Abi/WAVE complex.
            Our results suggest that NESH (Abi-3), like Abi-1 and Abi-2, is a component of
            the Abi/WAVE complex
        - reference_id: PMID:26428302
          supporting_text: >-
            NESH/Abi-3 was ectopically expressed in NIH3T3 cells, in which Abi-1, but not
            NESH/Abi-3, is expressed. The expression of NESH/Abi-3 caused degradation of
            endogenous Abi-1, which led to the formation of a NESH/Abi-3-based WAVE2 complex
  - term:
      id: GO:0035591
      label: signaling adaptor activity
    evidence_type: IBA
    original_reference_id: GO_REF:0000033
    review:
      summary: >-
        IBA annotation for signaling adaptor activity. ABI3 functions as an adaptor protein
        within the WRC, linking upstream signals to actin cytoskeleton regulation. It contains
        an SH3 domain and proline-rich regions typical of adaptor proteins. The SH3 domain
        interacts with PAK and IRSp53 (PMID:11956071, PMID:18480067).
      action: ACCEPT
      reason: >-
        ABI3 is a well-characterized adaptor protein. Its SH3 domain mediates protein-protein
        interactions and it serves as a bridge within the WRC to couple signaling to actin
        regulation. This accurately captures the molecular function of ABI3.
      supported_by:
        - reference_id: PMID:11956071
          supporting_text: >-
            The SH3 domain of NESH seems to interact with p21-activated kinase (PAK),
            which is involved in regulation of cell motility
  - term:
      id: GO:0098858
      label: actin-based cell projection
    evidence_type: IBA
    original_reference_id: GO_REF:0000033
    review:
      summary: >-
        IBA annotation for actin-based cell projection localization. ABI3 localizes to
        actin-based structures as a WRC component. Experimental evidence shows it at
        lamellipodia and potentially invadopodia (PMID:26428302).
      action: ACCEPT
      reason: >-
        Consistent with ABI3 function as a WRC component that regulates actin-based
        protrusions. Well-supported by the IDA evidence for lamellipodium localization
        and the broader role in actin-based structures.
  - term:
      id: GO:0030334
      label: regulation of cell migration
    evidence_type: IBA
    original_reference_id: GO_REF:0000033
    review:
      summary: >-
        IBA annotation for regulation of cell migration. Strongly supported by
        experimental evidence showing that forced expression of NESH/ABI3 suppresses
        cell motility and metastatic dissemination (PMID:11956071). ABI3 modulates
        migration through its effects on WRC-dependent actin dynamics.
      action: ACCEPT
      reason: >-
        Core function of ABI3. Regulation of cell migration is one of the best-characterized
        biological roles of ABI3, supported by multiple independent studies.
      supported_by:
        - reference_id: PMID:11956071
          supporting_text: >-
            every clone of NESH transfectants caused a marked reduction in motility,
            although the clones exhibited no significant differences in intrinsic cell
            growth compared with the control cells in vitro
  - term:
      id: GO:0005737
      label: cytoplasm
    evidence_type: IEA
    original_reference_id: GO_REF:0000044
    review:
      summary: >-
        IEA annotation from UniProt subcellular location mapping. Cytoplasmic
        localization is supported by IDA evidence (GO_REF:0000054) and NAS from
        PMID:11956071. UniProt states ABI3 localizes to the cytoplasm and
        colocalizes with PAK2 at the leading edge of cells.
      action: ACCEPT
      reason: >-
        Consistent with experimental evidence for cytoplasmic localization. Broad
        IEA mapping is acceptable given strong experimental support.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:16189514
    review:
      summary: >-
        Protein binding annotation from high-throughput interactome study. While ABI3
        does bind multiple proteins, 'protein binding' is uninformative. The more
        specific 'signaling adaptor activity' (GO:0035591) already captures the
        molecular function.
      action: MARK_AS_OVER_ANNOTATED
      reason: >-
        'Protein binding' is too vague to be informative. ABI3 does bind proteins but
        the specific adaptor function is better captured by GO:0035591 (signaling adaptor
        activity). High-throughput interactome data does not provide mechanistic insight.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:17101133
    review:
      summary: >-
        Protein binding from PMID:17101133 which demonstrated ABI3 interacts with
        WAVE2 complex components. This is more informative than generic protein binding
        as it reflects the specific WRC interaction, but the term itself is uninformative.
      action: MARK_AS_OVER_ANNOTATED
      reason: >-
        While the underlying interaction data from PMID:17101133 is high quality and shows
        specific binding to WAVE complex components, 'protein binding' is not an informative
        GO term. The SCAR complex membership and signaling adaptor activity annotations
        better capture this function.
      supported_by:
        - reference_id: PMID:17101133
          supporting_text: >-
            Immunoprecipitation revealed that NESH (Abi-3) is present in the Abi/WAVE complex
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:19060904
    review:
      summary: >-
        Protein binding from high-throughput binary interactome mapping study.
      action: MARK_AS_OVER_ANNOTATED
      reason: >-
        Generic 'protein binding' from high-throughput study is uninformative.
        More specific molecular function terms already exist for ABI3.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:21516116
    review:
      summary: >-
        Protein binding from next-generation sequencing interactome dataset.
      action: MARK_AS_OVER_ANNOTATED
      reason: >-
        Generic 'protein binding' from high-throughput study is uninformative.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:25416956
    review:
      summary: >-
        Protein binding from proteome-scale interactome mapping.
      action: MARK_AS_OVER_ANNOTATED
      reason: >-
        Generic 'protein binding' from high-throughput study is uninformative.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:27107014
    review:
      summary: >-
        Protein binding from inter-species protein-protein interaction network study.
      action: MARK_AS_OVER_ANNOTATED
      reason: >-
        Generic 'protein binding' from high-throughput study is uninformative.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:29892012
    review:
      summary: >-
        Protein binding from interactome perturbation framework study.
      action: MARK_AS_OVER_ANNOTATED
      reason: >-
        Generic 'protein binding' from high-throughput study is uninformative.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:32296183
    review:
      summary: >-
        Protein binding from reference binary protein interactome map.
      action: MARK_AS_OVER_ANNOTATED
      reason: >-
        Generic 'protein binding' from high-throughput study is uninformative.
  - term:
      id: GO:0005515
      label: protein binding
    evidence_type: IPI
    original_reference_id: PMID:40205054
    review:
      summary: >-
        Protein binding from multimodal cell maps study.
      action: MARK_AS_OVER_ANNOTATED
      reason: >-
        Generic 'protein binding' from high-throughput study is uninformative.
  - term:
      id: GO:0042802
      label: identical protein binding
    evidence_type: IPI
    original_reference_id: PMID:25416956
    review:
      summary: >-
        Self-interaction of ABI3 detected in high-throughput interactome study.
        UniProt interaction data confirms ABI3 self-interaction (NbExp=4).
      action: ACCEPT
      reason: >-
        ABI3 homodimerization is supported by multiple independent high-throughput
        studies and is recorded in IntAct. This is more informative than generic
        'protein binding' and may reflect a functional oligomerization relevant to
        WRC assembly or regulation.
  - term:
      id: GO:0042802
      label: identical protein binding
    evidence_type: IPI
    original_reference_id: PMID:32296183
    review:
      summary: >-
        Additional evidence for ABI3 self-interaction from reference interactome map.
      action: ACCEPT
      reason: >-
        Independent confirmation of ABI3 homodimerization. Duplicates with different
        references are acceptable.
  - term:
      id: GO:0002357
      label: defense response to tumor cell
    evidence_type: IEA
    original_reference_id: GO_REF:0000120
    review:
      summary: >-
        IEA annotation from combined automated methods, likely transferred from mouse
        ortholog data. The IMP annotation from PMID:21223585 provides direct experimental
        support showing ABI3 ectopic expression reduces tumor growth.
      action: ACCEPT
      reason: >-
        Consistent with the IMP-supported annotation from PMID:21223585 and with
        broader literature on ABI3 as a tumor suppressor. The IEA is broader but not
        incorrect.
  - term:
      id: GO:0010593
      label: negative regulation of lamellipodium assembly
    evidence_type: IEA
    original_reference_id: GO_REF:0000107
    review:
      summary: >-
        IEA annotation transferred from mouse ortholog. Supported by experimental evidence
        in PMID:26428302 showing that ABI3/NESH expression in NIH3T3 cells reduced WAVE2
        translocation to the plasma membrane and disturbed lamellipodial formation.
      action: ACCEPT
      reason: >-
        This is a well-supported function of ABI3. The ABI3-based WAVE2 complex is
        functionally distinct and impairs lamellipodial protrusion formation compared
        to ABI1-based complexes.
      supported_by:
        - reference_id: PMID:26428302
          supporting_text: >-
            the translocation of WAVE2 to the plasma membrane was significantly reduced
            and the formation of peripheral lamellipodial structures was disturbed
  - term:
      id: GO:0030027
      label: lamellipodium
    evidence_type: IEA
    original_reference_id: GO_REF:0000120
    review:
      summary: >-
        IEA annotation for lamellipodium localization. Consistent with IDA evidence
        from PMID:17101133 and IBA annotation.
      action: ACCEPT
      reason: >-
        Redundant with IBA and IDA annotations but not incorrect. Lamellipodium
        localization is well established for ABI3.
  - term:
      id: GO:0031209
      label: SCAR complex
    evidence_type: IEA
    original_reference_id: GO_REF:0000120
    review:
      summary: >-
        IEA annotation for SCAR complex membership. Consistent with IDA annotations
        from PMID:17101133 and PMID:26428302.
      action: ACCEPT
      reason: >-
        Core function. Redundant with IDA annotations but acceptable.
  - term:
      id: GO:0098794
      label: postsynapse
    evidence_type: IEA
    original_reference_id: GO_REF:0000107
    review:
      summary: >-
        IEA annotation transferred from rat ortholog via Ensembl Compara. ISS annotations
        from ARUK-UCL also support postsynaptic localization (dendritic spine, postsynaptic
        density). The WRC functions in dendritic spine morphogenesis, supporting synaptic
        localization. However, ABI3 is primarily enriched in microglia rather than neurons.
      action: KEEP_AS_NON_CORE
      reason: >-
        While WRC-mediated actin regulation at the postsynapse is conserved for ABI family
        members, ABI3 is primarily expressed in microglia in the brain, not neurons. The
        synaptic annotations may be more relevant to ABI1/ABI2 and transferred to ABI3
        by orthology. Keep as non-core pending direct evidence in neurons.
  - term:
      id: GO:0098885
      label: modification of postsynaptic actin cytoskeleton
    evidence_type: IEA
    original_reference_id: GO_REF:0000107
    review:
      summary: >-
        IEA annotation from rat ortholog. WRC-dependent actin modification at postsynapses
        is a known function of ABI family members. However, ABI3 is primarily microglial
        rather than neuronal in the brain.
      action: KEEP_AS_NON_CORE
      reason: >-
        Plausible by orthology and WRC function but ABI3 is not the primary ABI family
        member in neurons. This function may be more attributable to ABI1/ABI2.
  - term:
      id: GO:0098978
      label: glutamatergic synapse
    evidence_type: IEA
    original_reference_id: GO_REF:0000107
    review:
      summary: >-
        IEA annotation transferred from rat ortholog. Glutamatergic synapse localization
        may be more relevant to ABI1/ABI2 given ABI3 enrichment in microglia.
      action: KEEP_AS_NON_CORE
      reason: >-
        Transferred from rat ortholog. ABI3 is microglia-enriched in brain tissue and
        not primarily neuronal. This annotation may reflect function of other ABI
        paralogs rather than ABI3 specifically.
  - term:
      id: GO:1903077
      label: negative regulation of protein localization to plasma membrane
    evidence_type: IEA
    original_reference_id: GO_REF:0000107
    review:
      summary: >-
        IEA annotation from mouse ortholog. Supported by experimental evidence showing
        that ABI3 expression reduces WAVE2 translocation to the plasma membrane
        (PMID:26428302).
      action: ACCEPT
      reason: >-
        Well-supported by experimental data. ABI3-containing WAVE2 complexes show
        reduced translocation to the plasma membrane compared to ABI1-containing
        complexes, consistent with this annotation.
      supported_by:
        - reference_id: PMID:26428302
          supporting_text: >-
            the translocation of WAVE2 to the plasma membrane was significantly reduced
  - term:
      id: GO:0030036
      label: actin cytoskeleton organization
    evidence_type: ISS
    original_reference_id: GO_REF:0000024
    review:
      summary: >-
        ISS annotation transferred by curator judgment. ABI3 participates in actin
        cytoskeleton organization as a WRC component. The WRC activates Arp2/3-mediated
        actin nucleation and polymerization.
      action: ACCEPT
      reason: >-
        Core function of ABI3. As a WRC subunit, ABI3 directly participates in actin
        cytoskeleton organization. Well-supported by multiple studies showing effects
        on lamellipodia, cell protrusions, and actin-based structures.
  - term:
      id: GO:0002357
      label: defense response to tumor cell
    evidence_type: IMP
    original_reference_id: PMID:21223585
    review:
      summary: >-
        IMP annotation from PMID:21223585 showing that ABI3 ectopic expression reduces
        tumor growth in vitro and in vivo in thyroid and colon carcinoma cell lines.
        ABI3 expression is frequently lost in carcinomas, and re-expression reduces
        transforming activity, anchorage-independent growth, and in vivo tumor formation.
      action: KEEP_AS_NON_CORE
      reason: >-
        The experimental evidence is solid showing tumor-suppressive effects of ABI3
        re-expression. However, 'defense response to tumor cell' is not the most precise
        term for what was shown. The study demonstrates tumor suppressor activity through
        re-expression in cancer cells where ABI3 was silenced. This is more accurately
        described as negative regulation of cell proliferation or tumor suppression.
        Nevertheless, this is a secondary consequence of ABI3's primary role in actin
        regulation and cell migration, not a core evolved function.
      supported_by:
        - reference_id: PMID:21223585
          supporting_text: >-
            Ectopic expression of ABI3 was sufficient to lead to a lower transforming
            activity, reduced tumor in vitro growth properties, suppressed in vitro
            anchorage-independent growth and in vivo tumor formation while, cellular
            senescence increased
  - term:
      id: GO:2000774
      label: positive regulation of cellular senescence
    evidence_type: IMP
    original_reference_id: PMID:21223585
    review:
      summary: >-
        IMP annotation from PMID:21223585. ABI3 ectopic expression induced senescence
        in thyroid and colon carcinoma cells, accompanied by p21WAF1 upregulation and
        reduced ERK phosphorylation.
      action: KEEP_AS_NON_CORE
      reason: >-
        The experimental evidence for senescence induction is clear from PMID:21223585.
        However, this is likely a secondary consequence of ABI3 re-expression in cancer
        cells rather than a core evolved function. This effect is observed in the context
        of ectopic expression in cells where ABI3 was silenced, and the senescence
        phenotype may reflect disruption of oncogenic signaling rather than a primary
        ABI3 function.
      supported_by:
        - reference_id: PMID:21223585
          supporting_text: >-
            cellular senescence increased. These responses were accompanied by the
            up-regulation of the cell cycle inhibitor p21 WAF1 and reduced ERK
            phosphorylation and E2F1 expression
  - term:
      id: GO:0031209
      label: SCAR complex
    evidence_type: IDA
    original_reference_id: PMID:17101133
    review:
      summary: >-
        IDA annotation from PMID:17101133 demonstrating ABI3 is present in the Abi/WAVE
        complex by immunoprecipitation. This is a key finding establishing ABI3 as a
        bona fide WRC component.
      action: ACCEPT
      reason: >-
        Core function. Direct experimental evidence from immunoprecipitation showing
        ABI3 is a component of the WAVE complex.
      supported_by:
        - reference_id: PMID:17101133
          supporting_text: >-
            Immunoprecipitation revealed that NESH (Abi-3) is present in the Abi/WAVE
            complex. Our results suggest that NESH (Abi-3), like Abi-1 and Abi-2, is
            a component of the Abi/WAVE complex
  - term:
      id: GO:0043197
      label: dendritic spine
    evidence_type: ISS
    original_reference_id: GO_REF:0000024
    review:
      summary: >-
        ISS annotation transferred from a rat ortholog (F1M0R2) by ARUK-UCL curators.
        WRC components are known to localize to dendritic spines where they regulate
        spine morphogenesis. However, ABI3 is primarily microglial in the brain.
      action: KEEP_AS_NON_CORE
      reason: >-
        While WRC function at dendritic spines is conserved for ABI family members,
        ABI3 is microglia-enriched in the brain. This annotation may primarily reflect
        the function of ABI1/ABI2 in neurons, transferred by sequence similarity.
  - term:
      id: GO:0043198
      label: dendritic shaft
    evidence_type: ISS
    original_reference_id: GO_REF:0000024
    review:
      summary: >-
        ISS annotation transferred from rat ortholog. Similar considerations as for
        dendritic spine localization.
      action: KEEP_AS_NON_CORE
      reason: >-
        ABI3 is microglia-enriched rather than neuronal. This annotation may reflect
        function of other ABI paralogs. Keeping as non-core.
  - term:
      id: GO:0014069
      label: postsynaptic density
    evidence_type: ISS
    original_reference_id: GO_REF:0000024
    review:
      summary: >-
        ISS annotation transferred from rat ortholog. Postsynaptic density localization
        is well-established for WRC components, but ABI3 is primarily microglial.
      action: KEEP_AS_NON_CORE
      reason: >-
        Same reasoning as for dendritic spine. WRC function at the PSD is conserved
        for ABI family but ABI3 enrichment in microglia suggests this is not its
        primary localization context.
  - term:
      id: GO:0051015
      label: actin filament binding
    evidence_type: ISS
    original_reference_id: GO_REF:0000024
    review:
      summary: >-
        ISS annotation transferred from rat ortholog. ABI3 contains domains that could
        mediate interactions with actin-based structures, but direct actin filament
        binding by ABI3 itself has not been demonstrated. ABI3 functions as an adaptor
        within the WRC rather than directly binding actin filaments.
      action: UNDECIDED
      reason: >-
        There is no direct evidence for ABI3 binding actin filaments. ABI3 interacts
        with actin-regulatory complexes (WRC) but its function is as an adaptor, not
        an actin-binding protein per se. The ISS transfer may be from a different ABI
        paralog with distinct biochemical properties. More evidence needed to confirm
        direct actin filament binding by ABI3.
  - term:
      id: GO:0061001
      label: regulation of dendritic spine morphogenesis
    evidence_type: ISS
    original_reference_id: GO_REF:0000024
    review:
      summary: >-
        ISS annotation from rat ortholog. WRC regulates dendritic spine morphogenesis
        but ABI3 is microglia-enriched, not primarily neuronal.
      action: KEEP_AS_NON_CORE
      reason: >-
        WRC function in spine morphogenesis is well-established but likely mediated
        by ABI1/ABI2 in neurons. ABI3 is primarily expressed in microglia.
  - term:
      id: GO:0099151
      label: regulation of postsynaptic density assembly
    evidence_type: ISS
    original_reference_id: GO_REF:0000024
    review:
      summary: >-
        ISS annotation from rat ortholog. Similar considerations as other synaptic
        annotations.
      action: KEEP_AS_NON_CORE
      reason: >-
        ABI3 is microglia-enriched and not the primary ABI paralog at neuronal
        synapses. Keep as non-core.
  - term:
      id: GO:1900028
      label: negative regulation of ruffle assembly
    evidence_type: NAS
    original_reference_id: PMID:18480067
    review:
      summary: >-
        NAS annotation from PMID:18480067 which identified IRSp53 as a binding partner
        of NESH/ABI3. The paper is a brief letter identifying the interaction. Previous
        work showed ABI3 over-expression blocked PDGF-stimulated membrane ruffling.
      action: ACCEPT
      reason: >-
        Negative regulation of ruffle assembly is consistent with ABI3's role in
        modulating actin-based structures. ABI3 overexpression blocks PDGF-stimulated
        membrane ruffling, and ABI3-containing WAVE2 complexes impair protrusion
        formation (PMID:26428302). This is a direct consequence of ABI3's core function
        in modulating WRC activity.
      supported_by:
        - reference_id: PMID:26428302
          supporting_text: >-
            the translocation of WAVE2 to the plasma membrane was significantly reduced
            and the formation of peripheral lamellipodial structures was disturbed
  - term:
      id: GO:0010593
      label: negative regulation of lamellipodium assembly
    evidence_type: ISS
    original_reference_id: GO_REF:0000024
    review:
      summary: >-
        ISS annotation from mouse ortholog. Strongly supported by experimental
        evidence in PMID:26428302 showing ABI3-containing WAVE2 complexes impair
        lamellipodium formation.
      action: ACCEPT
      reason: >-
        This is a core function distinguishing ABI3 from ABI1/ABI2. ABI3-based
        WAVE2 complexes are functionally distinct and impair lamellipodial protrusions.
      supported_by:
        - reference_id: PMID:26428302
          supporting_text: >-
            the NESH/Abi-3-based WAVE2 complex was unable to help produce
            lamellipodial protrusions
  - term:
      id: GO:0031209
      label: SCAR complex
    evidence_type: IDA
    original_reference_id: PMID:26428302
    review:
      summary: >-
        IDA annotation from PMID:26428302 providing detailed characterization of the
        ABI3-based WAVE2 complex. Demonstrated that ABI3 expression leads to degradation
        of endogenous ABI1 and formation of an ABI3-based WAVE2 complex.
      action: ACCEPT
      reason: >-
        Core function. Independent confirmation of SCAR/WAVE complex membership
        with detailed functional characterization of the distinct ABI3-containing complex.
      supported_by:
        - reference_id: PMID:26428302
          supporting_text: >-
            The expression of NESH/Abi-3 caused degradation of endogenous Abi-1,
            which led to the formation of a NESH/Abi-3-based WAVE2 complex
  - term:
      id: GO:1903077
      label: negative regulation of protein localization to plasma membrane
    evidence_type: ISS
    original_reference_id: GO_REF:0000024
    review:
      summary: >-
        ISS annotation from mouse ortholog. ABI3 expression reduces WAVE2 translocation
        to the plasma membrane, as shown in PMID:26428302.
      action: ACCEPT
      reason: >-
        Well-supported by experimental data. ABI3-containing WAVE2 complexes show
        reduced membrane translocation compared to ABI1-containing complexes.
      supported_by:
        - reference_id: PMID:26428302
          supporting_text: >-
            the translocation of WAVE2 to the plasma membrane was significantly reduced
  - term:
      id: GO:0016020
      label: membrane
    evidence_type: HDA
    original_reference_id: PMID:19946888
    review:
      summary: >-
        HDA annotation from a study defining the membrane proteome of NK cells.
        ABI3 was detected in the membrane fraction by proteomics.
      action: ACCEPT
      reason: >-
        ABI3 as a WRC component can associate with membranes, particularly at the
        leading edge where it colocalizes with PAK2. Detection in membrane proteome
        of NK cells is consistent with this.
  - term:
      id: GO:0005737
      label: cytoplasm
    evidence_type: IDA
    original_reference_id: GO_REF:0000054
    review:
      summary: >-
        IDA annotation from LIFEdb based on intracellular localization of expressed
        fusion proteins in living cells. Consistent with UniProt subcellular location
        annotation.
      action: ACCEPT
      reason: >-
        Cytoplasmic localization is well-established for ABI3. Supported by multiple
        independent evidence sources.
  - term:
      id: GO:0018108
      label: peptidyl-tyrosine phosphorylation
    evidence_type: IDA
    original_reference_id: PMID:17101133
    negated: true
    review:
      summary: >-
        CORRECT negative annotation. PMID:17101133 explicitly tested and showed that
        "NESH (Abi-3) had no such effect" on promoting c-Abl-mediated phosphorylation,
        unlike Abi-1 and Abi-2 which do promote this activity. This negative annotation
        correctly captures that ABI3/NESH does NOT participate in peptidyl-tyrosine
        phosphorylation processes.
      action: ACCEPT
      reason: >-
        Important negative annotation that distinguishes ABI3 from its paralogs ABI1
        and ABI2. PMID:17101133 directly tested and demonstrated this difference.
      supported_by:
        - reference_id: PMID:17101133
          supporting_text: >-
            Although Abi-2, like Abi-1, promoted the c-Abl-mediated phosphorylation
            of Mena and WAVE2, NESH (Abi-3) had no such effect. This difference was
            likely due to their binding abilities as to c-Abl
  - term:
      id: GO:0030027
      label: lamellipodium
    evidence_type: IDA
    original_reference_id: PMID:17101133
    review:
      summary: >-
        IDA annotation from PMID:17101133. ABI3 was shown to be present in the
        Abi/WAVE complex which localizes to lamellipodia where it regulates
        Rac-dependent actin polymerization.
      action: ACCEPT
      reason: >-
        Direct experimental evidence supports lamellipodium localization of ABI3
        as part of the WAVE complex.
      supported_by:
        - reference_id: PMID:17101133
          supporting_text: >-
            Immunoprecipitation revealed that NESH (Abi-3) is present in the Abi/WAVE
            complex
  - term:
      id: GO:0030334
      label: regulation of cell migration
    evidence_type: IDA
    original_reference_id: PMID:11956071
    review:
      summary: >-
        IDA annotation from PMID:11956071 showing forced NESH/ABI3 expression
        suppresses cell motility. NESH transfectants showed marked reduction in
        motility and reduced tumor metastatic potential in vivo.
      action: ACCEPT
      reason: >-
        Core function. One of the earliest and best-characterized biological roles
        of ABI3. Direct experimental demonstration of cell migration regulation.
      supported_by:
        - reference_id: PMID:11956071
          supporting_text: >-
            every clone of NESH transfectants caused a marked reduction in motility,
            although the clones exhibited no significant differences in intrinsic
            cell growth compared with the control cells in vitro. The NESH
            transfectants also exhibited significant reduction in tumor metastatic
            potential in vivo
  - term:
      id: GO:0005737
      label: cytoplasm
    evidence_type: NAS
    original_reference_id: PMID:11956071
    review:
      summary: >-
        NAS annotation for cytoplasmic localization from PMID:11956071. The paper
        describes NESH as an intracellular SH3 adapter protein.
      action: ACCEPT
      reason: >-
        Consistent with other evidence for cytoplasmic localization. The paper
        describes cytoplasmic distribution and colocalization with PAK2 at the
        leading edge of cells.
      supported_by:
        - reference_id: PMID:11956071
          supporting_text: >-
            The SH3 domain of NESH seems to interact with p21-activated kinase (PAK),
            which is involved in regulation of cell motility
references:
  - id: GO_REF:0000024
    title: >-
      Manual transfer of experimentally-verified manual GO annotation data
      to orthologs by curator judgment of sequence similarity
    findings: []
  - id: GO_REF:0000033
    title: Annotation inferences using phylogenetic trees
    findings: []
  - id: GO_REF:0000044
    title: >-
      Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular
      Location vocabulary mapping, accompanied by conservative changes to GO
      terms applied by UniProt
    findings: []
  - id: GO_REF:0000054
    title: >-
      Gene Ontology annotation based on curation of intracellular
      localizations of expressed fusion proteins in living cells
    findings: []
  - id: GO_REF:0000107
    title: >-
      Automatic transfer of experimentally verified manual GO annotation
      data to orthologs using Ensembl Compara
    findings: []
  - id: GO_REF:0000120
    title: Combined Automated Annotation using Multiple IEA Methods
    findings: []
  - id: PMID:11956071
    title: >-
      Forced expression of NESH suppresses motility and metastatic
      dissemination of malignant cells.
    findings:
      - statement: >-
          NESH/ABI3 forced expression suppresses cell motility and metastatic
          dissemination. NESH interacts with PAK via its SH3 domain and decreases
          PAK phosphorylation at Thr402.
        supporting_text: >-
          every clone of NESH transfectants caused a marked reduction in motility,
          although the clones exhibited no significant differences in intrinsic cell
          growth compared with the control cells in vitro. The NESH transfectants also
          exhibited significant reduction in tumor metastatic potential in vivo.
  - id: PMID:16189514
    title: >-
      Towards a proteome-scale map of the human protein-protein interaction
      network.
    findings: []
  - id: PMID:17101133
    title: >-
      NESH (Abi-3) is present in the Abi/WAVE complex but does not promote
      c-Abl-mediated phosphorylation.
    findings:
      - statement: >-
          ABI3/NESH is present in the Abi/WAVE complex by immunoprecipitation but
          does not bind c-Abl and does not promote c-Abl-mediated phosphorylation
          of Mena or WAVE2, distinguishing it from ABI1 and ABI2.
        supporting_text: >-
          Immunoprecipitation revealed that NESH (Abi-3) is present in the Abi/WAVE
          complex. Our results suggest that NESH (Abi-3), like Abi-1 and Abi-2, is a
          component of the Abi/WAVE complex, but likely plays a different role in the
          regulation of c-Abl.
  - id: PMID:18480067
    title: >-
      Insulin receptor substrate protein 53 (IRSp53) as a binding partner
      of antimetastasis molecule NESH, a member of Abelson interactor protein
      family.
    findings:
      - statement: >-
          IRSp53 identified as a binding partner of NESH/ABI3. IRSp53 is involved
          in PDGF-stimulated membrane ruffling.
        supporting_text: >-
          Insulin receptor substrate protein 53 (IRSp53) as a binding partner of
          antimetastasis molecule NESH, a member of Abelson interactor protein family.
  - id: PMID:19060904
    title: An empirical framework for binary interactome mapping.
    findings: []
  - id: PMID:19946888
    title: Defining the membrane proteome of NK cells.
    findings:
      - statement: >-
          ABI3 detected in the membrane proteome of NK cells by high-throughput
          proteomics.
        supporting_text: >-
          The present study was initiated to define the composition of the membrane
          proteome of the Natural Killer (NK) like cell line YTS
  - id: PMID:21223585
    title: >-
      ABI3 ectopic expression reduces in vitro and in vivo cell growth
      properties while inducing senescence.
    findings:
      - statement: >-
          ABI3 re-expression in thyroid and colon carcinoma cells reduces transforming
          activity, inhibits anchorage-independent growth, suppresses in vivo tumor
          formation, and induces cellular senescence via p21WAF1 upregulation and
          ERK phosphorylation reduction.
  - id: PMID:21516116
    title: Next-generation sequencing to generate interactome datasets.
    findings: []
  - id: PMID:25416956
    title: A proteome-scale map of the human interactome network.
    findings: []
  - id: PMID:26428302
    title: >-
      The NESH/Abi-3-based WAVE2 complex is functionally distinct from the
      Abi-1-based WAVE2 complex.
    findings:
      - statement: >-
          ABI3 expression in NIH3T3 cells causes degradation of endogenous ABI1 and
          formation of a distinct ABI3-based WAVE2 complex that reduces WAVE2
          translocation to the plasma membrane and impairs lamellipodial protrusions.
          In v-src transformed cells, ABI3 promotes invadopodia formation under
          certain conditions.
  - id: PMID:27107014
    title: >-
      An inter-species protein-protein interaction network across vast
      evolutionary distance.
    findings: []
  - id: PMID:29892012
    title: >-
      An interactome perturbation framework prioritizes damaging missense
      mutations for developmental disorders.
    findings: []
  - id: PMID:32296183
    title: A reference map of the human binary protein interactome.
    findings: []
  - id: PMID:40205054
    title: >-
      Multimodal cell maps as a foundation for structural and functional
      genomics.
    findings: []
core_functions:
  - description: >-
      Component of the WAVE regulatory complex (WRC/SCAR complex), occupying the
      Abi subunit position. ABI3 forms a heteropentameric complex with WAVE2, CYFIP1,
      NAP1, and BRK1 that couples upstream signals (Rac, Arf GTPases) to Arp2/3-mediated
      actin nucleation and polymerization.
    molecular_function:
      id: GO:0035591
      label: signaling adaptor activity
    locations:
      - id: GO:0031209
        label: SCAR complex
    directly_involved_in:
      - id: GO:0030036
        label: actin cytoskeleton organization
    supported_by:
      - reference_id: PMID:17101133
        supporting_text: >-
          Immunoprecipitation revealed that NESH (Abi-3) is present in the Abi/WAVE
          complex. Our results suggest that NESH (Abi-3), like Abi-1 and Abi-2, is
          a component of the Abi/WAVE complex
      - reference_id: PMID:26428302
        supporting_text: >-
          The expression of NESH/Abi-3 caused degradation of endogenous Abi-1,
          which led to the formation of a NESH/Abi-3-based WAVE2 complex
  - description: >-
      Modulates actin-dependent cell migration. ABI3 expression suppresses cell motility
      and metastatic dissemination. The ABI3-containing WAVE2 complex is functionally
      distinct from the ABI1-containing complex, reducing WAVE2 translocation to the
      plasma membrane and impairing lamellipodium formation. ABI3 also interacts with
      PAK and IRSp53 via its SH3 domain to regulate migration-related signaling.
    molecular_function:
      id: GO:0035591
      label: signaling adaptor activity
    directly_involved_in:
      - id: GO:0030334
        label: regulation of cell migration
    supported_by:
      - reference_id: PMID:11956071
        supporting_text: >-
          every clone of NESH transfectants caused a marked reduction in motility,
          although the clones exhibited no significant differences in intrinsic
          cell growth compared with the control cells in vitro
      - reference_id: PMID:26428302
        supporting_text: >-
          the translocation of WAVE2 to the plasma membrane was significantly reduced
          and the formation of peripheral lamellipodial structures was disturbed
  - description: >-
      Negative regulation of lamellipodium assembly and membrane ruffling.
      ABI3-based WAVE2 complexes specifically impair the formation of peripheral
      lamellipodial structures, distinguishing ABI3 from ABI1 and ABI2 in terms
      of protrusion type regulation.
    molecular_function:
      id: GO:0035591
      label: signaling adaptor activity
    directly_involved_in:
      - id: GO:0010593
        label: negative regulation of lamellipodium assembly
    supported_by:
      - reference_id: PMID:26428302
        supporting_text: >-
          the NESH/Abi-3-based WAVE2 complex was unable to help produce
          lamellipodial protrusions
suggested_questions:
  - question: Does ABI3 directly bind actin filaments, or does it solely function as an adaptor within the WRC?
  - question: Is ABI3 expressed in neurons as well as microglia, and does it have neuron-specific functions?
  - question: How does the S209F Alzheimer disease risk variant affect ABI3 incorporation into the WRC and microglial function?
  - question: What is the precise mechanism by which ABI3 phosphorylation at S213/S216/S342 regulates its WRC incorporation?
suggested_experiments:
  - description: Direct actin filament binding assays (e.g., co-sedimentation) with purified ABI3 protein to test whether ABI3 has intrinsic actin-binding activity
  - description: Single-cell RNA-seq or spatial transcriptomics to clarify ABI3 expression across brain cell types in human tissue
  - description: In vitro WRC reconstitution with ABI3 vs ABI1 to measure differences in Arp2/3 activation kinetics
  - description: CRISPR knock-in of the S209F variant in human iPSC-derived microglia to assess effects on migration, phagocytosis, and WRC dynamics